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This work aims developing different kinds of microneedles with various configurations and 
functions for transdermal drug delivery applications. Although the microneedle technology has been 
developed for decades, limited by the process to realize the 3D sharp tip which is critical for skin penetration, 
it is not easy to merge microneedle technique with other functional components and systems to achieve 
more complex functions. Most of the studies only focus on changing the materials and geometries, 
evaluating the performance and finding new applications. Here we developed a very unique technology 
called drawing lithography for the assembly of SU-8 and maltose sharp tips at the final step of the 
fabrication process, which is compatible with most of the conventional thin film technology and allows us 
to explore more possibilities about integrating other functional components and sophisticated system with 
microneedles. A novel Carbon Nanotubes (CNTs) filter, which can be used for selective transport of bio-
molecules, is integrated within the microneedles. Thus, haemagglutinin, single-stranded DNA, glucose and 
insulin can be selectively delivered depending on their different physical dimensions, shapes and polarities 
by controlling the pressure and electric bias applied. We also integrated microneedles with a complex 
system to make a self-powered, flexible microneedle skin patch which is suitable for self-administrated 
insulin delivery. A pneumatic pump and check-valves are designed for manually controlled drug loading 
and delivery. In order to have a precise dose control required by insulin delivery, a delivery volume sensor 
based on triboelectric mechanism is designed and optimized. For powering other functional components to 
be integrated in the future, a low cost power source, which leverages the stacked layer triboelectric energy 
harvester design, is characterized to achieve 33μw output power. Moreover, in order to make the device 
truly wearable, dry adhesive technique is further applied to make the device able to be attached onto any 
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Chapter 1 Introduction of microneedle 
Drug delivery research has extensively pursed on how to transport proteins, DNA, genes, 
antibodies and vaccines efficiently and safely to human bodies in recent years. The conventional 
drug delivery approaches, such as oral administration and hypodermic injection, have their own 
limitations because a drug may be inactive through phase I metabolism during oral delivery [1], 
while the hypodermic injection requires trained personnel [2]. In order to overcome these 
drawbacks, transdermal drug delivery has been taken as a safe, easily accessible and patient 
friendly approach [3]. The normal biomolecules, however, cannot passively diffuse through the 
dermal layers of skin due to their unfavorable hydrophilicity and macro size [4].  With the help of 
microneedles which can create microchannels on the skin surface by penetrating the outmost layer, 
i.e. stratum cornuem (SC), biomolecules can permeate into the tissue under the skin locally [5]. 
Since these microneedles are only a few hundred micrometers in length, the penetration depth is 
superficial enough not to touch nerve receptors in the lower reticular dermis, which leads the whole 
administration to be painless [6]. It is promising that this microneedle-based transdermal delivery 
approach will offer a self-management, patient-friendly and efficient administration route for drug 
delivery. 
Since the first papers were published on drug delivery using microneedles in the late 1990's, 
research activity has grown exponentially (Figure 1.1), which has led to published clinical trials, 





Figure 1.1 1 Cumulative number of publications on microneedles. The number of publications 
was determined by searching the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/) and 
Web of Science (http://apps.webofknowledge.com) on 25 November 2011 using the search terms 
“microneedle”, “microfabricated needle”, and “nanopatch”. Conference proceedings were 
excluded. 




Figure 1.2 2 Methods of drug delivery to the skin using microneedles (MN). [8] 
For an optimized delivery effect, microneedle chips are particularly desired to remain in the 
precise location and maintain the fluid communication with the tissues beneath the SC layer for an 
extended period. However, the skin is contoured and deformable. Conventional microneedle 
patches with a rigid and planar substrate which is made by silicon, stainless steel or nickel may 
encounter a difficulty to be attached tightly on the skin surface. Flexible microneedle patch has 
been developed to integrate polymer microneedles on a on a flexible substrate to solve this problem. 
Since fabricating tapered shape is not a standard process in the conventional MEMS technology, 
microneedles fabrication becomes the most critical part in the flexible microneedle patch. In 
general, these microneedles can be categorized as solid microneedles for tissue pretreatment, drug-
coated microneedles, dissolving microneedles and hollow microneedles. As shown in 
schematically in Figure 1.2, each of these microneedles enable drug delivery by different 
mechanisms.  
1.1.1 Solid Microneedles  
Solid microneedles are patterned into sharp geometry which can be used to create microchannel 
on the skin. The drug is usually loaded into a flexible substrate under the microneedle array. When 
the flexible skin patch is applied on the skin, the microneedles penetrate into the skin and drugs 
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can be used either for local effect or uptake by capillaries for systemic treatment. The development 
of polymer microneedles has focused on providing sufficient mechanical strength through different 
materials, including polylactic acid (PLA) [9], polymethylmeth-acrylate (PMMA)[10], SU-8 [11] and 
maltose [12].  
Solid polymer microneedles are normally patterned with unconventional process due to their 
tapered 3-dimensional structures.  The most common way for this tapered structure fabrication is 
inclined ultraviolet (UV) exposure technology [13]. When a photomask and a negative thick 
photoresist coated substrate are fixed together, its holding stage is tilted and rotated to a UV source. 
The reflected UV at the interface between the resist and the substrate is exploited as well as the 
incident UV. With the control of tilted degree and exposure dosage, the polymer photoresist can 
be patterned into sharp tips. Except UV source, deep X-ray exposure is also deployed to fabricate 
the microneedle structures, known as the lithography, electroplating and molding (LIGA) 
technique [14]. It can be used to fabricate polymer microneedles as tall as a few millimeters with a 
high aspect ratio using standard contact lithography equipment, which is a challenging in the UV 
rage due to the low optical absorption rate of the polymers. Moreover, a two-photon-initiated 
polymerization method is utilized to fabricate microneedles structure. A near-infrared ultrashort-
pulsed laser is focused into a photocurable resin to form three-dimensional (3D) microstructures 




Figure 1. 3 (a) Out-of-plane polycarbonate microneedle sheets produced by the hot embossing 
process [16]. (b)Array of polylactic acid microneedles made by thermal molding[17]. (c) PMMA 
microneedle fabricated by deep X-ray exposure[10]. (d) SU-8 microneedle fabricated by RIE 
etching[18]. 
1.1.2 Coated Microneedles 
    Microneedles not only can be used for penetration purpose, but also as vehicles to carry and 
deposit drug within the skin or other tissue. Drugs can be coated on the microneedle surface and 
subsequently diffuse into tissues. In this way, the desired dose of drugs is delivered into tissue 
quickly upon insertion of the microneedles. Microneedles have been coated by a variety of 
processes. The most common way is dipping or spraying the microneedles using an aqueous 
solution often has increased viscosity to retain more of the formulation on the microneedles [19]. It 
can be achieved by dipping microneedles once or repeal into a large reservoir [20] or microcells [21] 
of coating solutions.  Layer-by-layer coating techniques have also been applied into microneedle 
coating [22]. DNA or protein are demonstrated to be coated onto microneedles by alternately 
dipping into two solutions containing oppositely charged solutes. The negatively charged DNA 
and positively charged polymer can form a polyelectrolyte multi-layer. In addition to optimizing 
coating formulations, microneedle design and its advanced fabrication technique are also critical 
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to facilitate coated microneedle performance. For example, 3D groove-embedded microneedle has 
been reported to increase coating formulation amounts [23]. Microneedles with pocketed structure 
are demonstrated to facilitate better drug targeting in skin and to administer liquid coatings [24].  
1.1.3 Dissolving Microneedles 
Compared with coated microneedles, polymer microneedles also have been developed to 
completely dissolve in the skin and thereby leave behind no biohazardous sharps waste after usage. 
Biocompatible and water-soluble materials, such as sugars, are used to fabricate these dissolvable 
microneedles. Except that the dissolvable microneedles can penetrate skin surface as solid 
microneedles, drugs also can be mixed with the microneedle fabrication materials or encapsulated 
inside the microneedles to release into the skin.  
Dissolving microneedles usually are fabricated by micro-molds. Micro-molds with specified 
tapered structure are filled with melted polymers. After these polymers are solidified or 
polymerization in the mold, microneedles with sharp tips are integrated with drug formulations. 
Various materials including carboxymethylcellulose (CMC) [25], chondroitin sulfate [26], 
polyvinylpyrrolidone (PVP) [27],  polylactic acid co-polymers (PLGA) [28], and fibroin [29] have 
been deployed to fill into the mold cavities to form microneedles. Since the microneedles may not 
be entirely inserted into the skin, the drug is desired to be only encapsulated into the tip part for 
higher efficiency. It can be achieved by a particle-based molding method [30], forming multiple-




Figure 1.4 Dissolving microneedles made by (a) bovine serum albumin [33](b) chondroitin 
sulfate[31] (c) polyvinylpyrrolidone [34](d) polyvinyl alcohol [35]. 
1.1.4 Hollow Microneedles 
Hollow microneedles provide a conduit for drug delivery into the skin or other tissues. The most 
obvious advantage of hollow microneedles is that it allows pressure driven-flow of large dosage 
solution. Similar to conventional hypodermic injections, the pressure applied to hollow 
microneedles can modulate drug flow rate. It enables a rapid bolus injection, a slow infusion or a 
time-varying delivery rate with a single flexible microneedle patch. Generally there are two types 
of hollow microneedle designs. One of them mimics the traditional hypodermic needle with a 
single microneedle [36]. The other type is an array of multiple hollow microneedles [37]. The 
advantage for hollow microneedle array device is that it can deliver liquid formulation to a wide 




Figure1. 5 Hollow microneedle fabricated by microinjection molding [39], X-ray exposure [40], UV 
lithography [41] and two photon polymerization [42].  
Even though hollow microneedles have been fabricated directly from a rigid substrate using 
standard MEMS techniques including deep reactive ion etching [43], wet chemical etching [44] and 
laser micromachining [37],  innovative fabrication methods are developed to make polymer hollow 
microneedles for flexible devices. Polyphenylsulfone polymer is shown to be drilled and milled to 
create beveled tip shape and hollow structure [45]. A digital micro mirror stereo lithography 
instrument is used to fabricate hollow polymer microneedles by polymerization of liquid resin [46]. 
The LIGA technique is utilized to form hollow microneedles by exposing X-ray through a mask 
onto PMMA [47]. Direct tow-photon polymerization in a laser based rapid prototyping system is 
also used to form hollow polymer microneedles [48] (Figure 1.5).  
1.2 Microneedle made by drawing lithography process 
1.2.1 Theory of drawing lithography 
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Drawing lithography technology is based on the viscous property of a polymer in the glass 
transition to realize a 3D structure. The glass transition is a kinetic process between a solid state 
and liquid state of any amorphous polymer material. When a melted liquid polymer cools down to 
Tg, the amorphous portion of the polymer gradually becomes a more viscous and glassy liquid 
because thermal molecular motions decrease. As temperature decreases below Tg, the glassy liquid 
turns into a solid state because of the structural rearrangements with little relative mobility.  
 
Figure 1. 6 Viscosity change with temperature and drawing point [49]. 
When a drawing plate is induced to form microneedles structure, drawing lithography is 
characterized by an elastic deformation of polymer materials in the glassy transition. Initially, a 
polymer material with glassy state is placed between a substrate and drawing plate. A liquid-plate 
interfacial adhesion is initiated when the drawing plate contact the glassy liquid on the substrate. 
Subsequently, the polymer with glassy state is elongated by drawing the plate. A glassy structure 
is generated between the substrate and substrate. Since the gravitational force and inertial force are 
negligible, the geometry of the glassy structure is mainly modulated by the extensional strain force 
from the drawing plate and the fixed coating plate (Figure 1.7). This glassy structure is stretched 
by the drawing plate and fixed coating plate from opposite directions. Since the contact area with 
coating plate is much larger than the contact area with drawing plate, the stretching force is 
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stronger from the fixed coating plate. As the drawing plate rise up, the glassy structure under the 
stretching force will extensional deform. The radius in the top curvature near the drawing plate is 
smaller than that near the fixed coating plate, which induces a wasp-waist-shape bridge. As a result 
of the temperature gradient through the glassy structure and change of drawing speed, the 
difference of stretching force in the opposite directions become so large that the extension 
deformation cannot remain a steady-state. The breakage of the glassy structure will form a tapered 
microneedle.   
Previously, this drawing lithography process has been applied to fabricate 3 types of 
microneedles: continuous drawing for an ultra-high aspect ratio (UHAR) hollow microneedle, 
stepwise controlled drawing for a dissolving microneedle and drawing with antidromic isolation 
for a hybrid electro-microneedle (HEM).  
 
Figure 1. 7 Extensional deformation from the fixed coating surface in the glass transition. The 
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position of narrow necking is situated in the upper part of the intermediate liquid bridge by the 
axial difference of surface tension [50]. 
1.2.2 UHAR hollow microneedle 
The UHAR hollow microneedle can be fabricated from a SU-8 based drawing lithography 
process as shown in Figure 1.8. SU-8 polymer is used as the drawing material because its viscosity 
was easily controlled by temperature. The non-exposed SU-8 has a Tg of 50-55 ̊C[51] showing 
significant increase of viscosity by the temperature cooling down to Tg from high 
temperature(Figure1.8). SU-8 presents a possibility as a drawing substrate, and a hollow 






Figure 1. 8 Continuous drawing to produce a 3D UHAR microneedle mold. (A) The glass 
transition history of the SU-8 polymer in the cooled-down temperature. The inset shows a drawing 
system with patterned pillars for drawing lithography. (B) After the SU-8 contacted the patterned 
pillar, drawing lithography was performed. (C) Drawing caused the appearance of an extended 
conical-shaped bridge between the plate and pillar in the glass transition. (D) The desired liquid 
bridge was cured to generate a rigid structure. (E) The separation of the 3D microstructure bridge 
at the narrow necking position by isolation drawing produced the UHAR solid microneedle molds. 
The hollow metallic microneedle is produced by nickel electroplating using the fabricated 
3D microneedle mold, thus, its geometry depends on the shape of the mold. For nickel 
electroplating, a seed layer was deposited in the microneedle mold using Tollens’ reaction (Figure 
1.9(A)) [52,53]. The upper end of the mold was subsequently protected using enamel as a 
32 
 
metalplating resistor (Figure 1.9(B), see inset). The nickel electroplating was performed until the 
desired wall thickness was obtained by controlling the plating time (Figure 1.9(C)). Next, the SU-
8 microneedle mold and enamel were eliminated using an SU-8 remover (Figure 1.9(D)), 
producing a hollow metallic microneedle array. Although negative photoresist substances such as 
SU-8 are typically difficult to remove after UV irradiation due to chemical changes [54], in drawing 
lithography, the non-exposed SU-8 is easily eliminated by SU-8 removal. 
 
Figure 1. 9 The fabrication of hollow metallic microneedles from solid microneedle molds. (A) 
Chemical deposition on the solid microneedle molds. (B) The upper portion of the microneedle 
mold was coated with an electroless material using a drawing system. The inset shows the tip 
protection with enamel. (C) Nickel electroplating on conducted solid microneedle molds. The 
inset shows specific nickel electroplating on the conductive seed layer. (D) The hollow metallic 
microneedle array was created upon elimination of the electroless protection and the SU-8 
microneedle mold. 
Scanning electron microscopy revealed the microneedle mold had a tapered conical shape 
with a 20 µm flat tip diameter and a 300 µm base, yielding an aspect ratio over 100 (Figure 
1.10(A)). The size of the hole in the hollow microneedle corresponded to the diameter of the mold 
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at the top. A 20 µm needle diameter is large enough to allow passage of molecules such as target 
drugs while minimizing skin damage. Furthermore, the conical shape of the 300 µm base provides 
support for penetration of the skin barrier. Although the hollow metallic microneedle was shorter 
than the mold due to the enamel coating of the mold which occupied 200 µm of the mold, the 
UHAR hollow microneedles had a length of 2 mm (Figure 1.10(B)). 
 
Figure 1. 10 UHAR solid microneedle molds and hollow metallic microneedles. (A) The 
microneedle mold had a tapered conical shape with a 20 μm flat tip diameter, a 300 μm base, and 
an aspect ratio over 100. (B) A 3 by 3 array of hollow UHAR microneedles with a length of 2000 
μm and an inner diameter of 20 μm. 
1.2.3 Stepwise controlled drawing for a dissolving microneedle 
Maltose has been widely used as a safe polymer for the encapsulation of biomolecules[55], and 
is dissolved easily by the hydrolytic cleavage of maltose-glucoamylase in the skin [56]. In particular, 
maltose can be used as a structural material for the fabrication of dissolving microneedles because 
the glass transition of the maltose, thus the viscosity, was easily regulated by manipulating 
temperature during drawing. Maltose became liquid at temperatures over its Tm (102~103 ̊C), and 
the viscosity of the liquid maltose progressively increased with cooling until Tg (95±4 ̊C) [57,58] and 
then further cooling past the Tg induced a solid state. The viscosity change in the maltose glass 
transition provided the conditions for the drawing lithography.  
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The maltose, however, showed a dramatic change of viscosity in the glass transition in a short 
temperature range as shown in Figure 1.11(A) and the continuous drawing of maltose showed the 
different shapes of the dissolving microneedle depended on the maltose viscosity. When the 
drawing was performed at Tm, a 3D structure was not produced even at a low drawing rate, 
resulting in drawing failure, because the surface tension was more than the tensile stress of the 
extending maltose during drawing. Although drawing at a slightly lower temperature 
approximating Tm can elongate a glassy maltose quickly, the temporary extensional deformation 
can become a capillary break-up by quick self-thinning. 
This break-up can be prevented when drawing is applied between Tm and Tg at drawing point 
b due to increase in the shear viscosity which increased the initial planar extensional viscosity of 
maltose, and axial drawing of 400 µm/s for 3 s created a bat shape (Figure 1.11(B)). The general 
position of narrow necking from a coated polymer in a glass transition is settled into the upper part 
of the intermediate liquid bridge because surface tension in the bottom region is bigger than in the 
top region. However, extensional deformation in the short glass transition of maltose showed an 
entirely different aspect from the normal extensional deformation model. The short-term of the 
glass transition induced a relatively fast alteration to the solid at the top region of the liquid bridge, 
and strain-hardening of the top region had no direct influence from surface tension. Consequently, 
the bottom region near the fixed coating surface presented a local surface tension within the total 
extensional structure, resulting in the lower narrow necking position than the intermediate liquid 
bridge. Local surface tension in the bottom region led to irregular bat-shaped extensional 
deformation. Therefore, the fabrication yield of the bat shape was low due to the breakage at the 
narrow necking near the bottom during isolation drawing. 
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As another approach, extensional deformation in drawing point c produced a cylinder shape 
with a blunt tip of 200 µm diameter, which is the same as the pillar diameter shown in Figure 
1.11(C). The surface tension at Tg is suddenly reduced as the fluid like response above Tg 
transitions to solid-like response below Tg. As a result, the drawing at Tg formed a cylinder column 
without narrow necking by homogeneous extensional flow without direct influence from surface 
tension as an ideal extensional deformation model. Although continuous drawing lithography 
suggested the possibility of the direct fabrication of a dissolving microneedle from maltose, a blunt 
cylinder was not applicable as a microneedle for transdermal drug delivery because the shape 
rendered skin penetration difficult; precise control of the drawing was required for the fabrication 
of a sharp microneedle capable of penetrating the skin. 
Finally, stepwise controlled drawing lithography was designed to shape a particular sharp-
conical microneedle by combining the above 2 continuous drawings (Figure 1.11(D)). The 
primary drawing of 400 µm/s for 1 s produced a wasp-waist bridge with a bat shape between the 
pillar and the maltose surface with a diameter of 60 µm at drawing point b by the irregular 
extensional deformation model. Because the main drawing (400 µm/s speed for 3 s) was performed 
at drawing point c after the wasp-waist bridge was produced, the wasp-waist bridge behaved like 
a pillar resulting in a sharp cylinder column with a total height of 1500 µm. After curing the 
structure, the upper site of narrow necking in the bridge structure was separated from the sharp-
conical cone microneedle by isolation drawing. Using this stepwise controlled drawing, the bat 
and cylinder shape, which were not suitable as a microneedle structure, were avoided and a sharp 
conical cone shape was produced from the drawn 3D wasp-waist bridge (Figure 1.11(D)) with 
1200 µm length, and 60 µm flat tip diameter. Additionally, the authors’ proposed stepwise 
controlled drawing technique can flexibly change the length of a dissolving microneedle by 
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controlling the drawing rate and time. This length flexibility of a microneedle can facilitate the 
local delivery of a drug to the specific clinical point of skin [59-60], and thus overcome the limitation 






Figure 1.11 The stepwise controlled drawing lithography for fabrication of a dissolving 
microneedle. (A) The viscosity change with temperature and drawing point in the glass transition 
history of maltose. Drawing point a at Tm, drawing point b at the middle of Tm and Tg, and drawing 
point c at Tg. After sub-Tg, elongated structures became cured solid. (B) Bat shapes were produced 
by continuous drawing at drawing point b. (C) Cylinder shapes were fabricated by continuous 
drawing at drawing point c. (D) Sharp-conical cone shapes were fabricated by stepwise controlled 
drawing, primary drawing at drawing point b and main drawing at drawing point c. After curing 
was completed, the fabricated 3D structures were separated from narrow necking by additional 
isolation drawing at sub-Tg. 
 
1.2.4 Monolithic fabrication of a HEM 
The monolithic fabrication of a HEM was possible by using an electrode as the pillar 
resulting in the integration of a dissolving microneedle on an electrode as shown in Figure 1.12(A). 
An electrode with a diameter of 300 µm, a lift-up of 300 µm, and a pitch of 1mm was made in a 
5×5 array in a 1 cm circle from an aluminum plate using a computerized numerical control machine. 
The HEM electrode contacted the coated liquid maltose at a temperature greater than the Tm of 
maltose. Because the dramatic change in maltose viscosity in the glass transition (Tm ~ Tg) 
provides a critical condition for the successful elongation of dissolving microneedles by drawing 
lithography. Drawing of the electrode was performed at the middle of the glass transition to 
produce a 3D elongated structure with a bat shape by irregular extensional deformation (Figure 
1.12(B)). These elongated bat-shape structures were cured by cooling the maltose to a temperature 
lower than the Tg (at 80 C̊), and liquid maltose perfectly became solid maltose (Figure 1.12(C)). 
Subsequently, the bottom of the cured bat-shape structures was isolated from the fixed coating 
surface by remelting the maltose coating at a temperature greater than the Tm. This antidromic 
technique with remelting created the bell-shaped dissolving microneedle with an ultra-sharp tip 
diameter, and facilitated the monolithic hybrid assembly of a dissolving microneedle on an 
electrode (Figure 1.12(D)). The dissolving microneedle of the HEM had a geometric bell shape 
with an ultra-sharp tip diameter of 5 µm and a length of 400 µm (Figure 1.12(E)). Dissolving 
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microneedles and electrodes were integrated into monolithic HEMs of a 5 × 5 array (Figure 
1.12(F)). 
 
Figure 1. 12 The monolithic fabrication of the HEM by drawing lithography with antidromic 
isolation. (A) Liquid maltose, melted at a temperature greater than its Tm, was coated on a planar 
surface, and contacted with the 5 × 5 array electrodes of the HEMs as a drawing pillar. (B) The 
glassy maltose in glass transition between Tm and Tg was elongated by drawing of electrodes. (C) 
After lowering the temperature to sub-Tg, the elongated 3D structures were cured to a solid state. 
(D) The coating surface was melted at a temperature greater than Tm to isolate elongated 3D 
structures from the 2D coating surface and this antidromic isolation fabricated the dissolving 
microneedles of the HEMs. (E) A bell-shaped dissolving microneedle of the HEM had an ultra-
sharp tip diameter of 5 µm and a length of 400 µm. A dissolving microneedle and an electrode 
were integrated into a monolithic HEM. (F) A 5 × 5 array of fabricated HEMs. 
 
1.3 Motivation of integrate microneedles with functional components 
In summary, microneedle device has been demonstrated with all kinds of materials and 
processes for different applications. For the conventional microneedles, the process to make the 
whole microneedle device is affected by the process to realize the sharp tip either by molding or 
etching. Because the process to realize the 3D sharp tip is normally not compatible with other thin 
film processes. Thus, it is difficult to integrate the microneedle with other functional components 
to realize other specific applications.  
However, by leveraging the drawing lithography process, the sharp tip assembly can be the last 
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step of the microneedle device. It means that the compatibility of the process to make the sharp tip 
is not a main concern in the design of the microneedle device. Therefore, more functional 
components, such as microfluidic control system and nanofilters, are feasible to be integrated with 
microneedle.  
Moreover, microneedle is just a key component for a wearable medical device which is suitable 
for self-managed drug delivery.  With the quickly increasing number of aging people all around 
the world, such one stop medical care solution, including disease detection and drug delivery, is 
desired more than ever.  A complete wearable medical device should include the functions of skin 
penetration, fluidic control system for drug loading, drug delivery and volume control, disease 
symptom sensor for result feedback, energy source enabling self-powering and self-fixation onto 
skin. However, such integrated system is still uninvestigated.  The challenge mainly comes from 
how to realize mechanical structure for the functions such as fluidic control, energy harvester by 
soft and bio-compatible materials required for medical application. Initiating the system-level 
integration of all the functional components is meaningful for the future development of wearable 
drug delivery skin patch. 
In this thesis, we will explore the feasibility of integrating the microneedles by drawing 
lithography with other functional components to realize a drug delivery system for specific 
applications which are not demonstrated before. In Chapter 2, we will first improve the drawing 
lithography process and assemble both maltose and SU-8 sharp tips onto hollow micro-tubes to 
realize a continuous drug delivery. Based on the microneedle configuration with SU-8 sharp tips 
mentioned in Chapter 2, in Chapter 3, we integrated CNT nanofilters within to realize a selective 
drug delivery. Different drug molecules in the same solution can be delivered by applying different 
conditions. This technique will enable a programmable drug delivery by using microneedle device 
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in the future. To realize a wearable drug delivery device which is strongly desired, we plan to make 
a whole microneedle device flexible. However, the needle breakage during the skin penetration 
causes problems for the microneedle assembled onto soft substrates. To overcome this issue, in 
Chapter 4, a bendable microneedle is developed. This bendable microneedle can adapt the curvy 
skin surface and avoid the needle breakage during skin penetration. By using this bendable 
microneedle, we further realize a sophisticated skin patch in Chapter 5. In this skin patch, we add 
the triboelectric energy harvester (TEH) as a power source for the active component to be 
integrated in the future. Another major issue for the microneedle skin patch is that the volume of 
the drug delivered cannot be well controlled. Previously the delivery volume can be controlled by 
syringe pump. However, as a standalone device, a volume sensor is necessary to measure how 
much drug to be delivered, especially for the application of insulin delivery. In Chapter 6, we use 
the similar TEH demonstrated in Chapter 5 as a liquid volume sensor and integrate it within the 




1. Chapter 2 Drawing Lithography Technology for 
fabrication of bio-dissolvable and non-bio-dissolvable 
microneedles  
Microneedles fabrication is the most critical part in the development of flexible microneedle 
patch. As we addressed in the chapter 1, conventional fabrication for microneedles are time 
consuming and expensive. Drawing lithography technology is an innovative maskless approach in 
which a 3D polymer structure is directly extended from 2D viscous polymer materials to form 
ultrahigh-aspect-ratio microneedles. The straightforward process does not need any special 
equipment and is compatible to the other MEMS fabrication procedures. It is a new technique to 
overcome the drawbacks in conventional fabrication technologies and able to develop 
microneedles with various materials on the flexible microneedle patch. In this chapter, we will 
introduce two different kinds of microneedles based on this drawing lithography process.  
2.1   Drawing Lithography Technology for Making Flexible and Biodissolvable 
Microneedle patch 
In transdermal drug delivery, the delivery performance strongly depends on the molecular size 
of the drug. Delivery of large molecular drugs such as insulin has been already found to encounter 
an efficiency problem [61]. Combining dissolvable microneedles with microfluidic components is 
a promising way since this method can apply pressure on the drug solution to facilitate the large 
molecular drug diffusion process. We will demonstrate a new method based on drawing 
lithography technology to achieve this purpose. In order to overcome the barrier of SC layer, sharp 
dissolvable maltose tips are created on top of SU-8 vertical microtubes. After the maltose tips 
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penetrate into the skin and are dissolved by body fluid, a large volume of the desired drug will be 
delivered through SU-8 microtubes. 
2.1.1 Design and Fabrication 
2.1.1.1 Design Considerations 
   In this flexible device, we leverage the unique features of maltose based microtips, i.e., high 
mechanical strength and biodissolvability, and validate the feasibility of integration of sharp 
maltose tips on top of SU-8 microtubes in the present study (Figure 2.1). After sharp maltose tips 
perforating the SC layer of the skin, maltose tips will be dissolved in the body fluid within a few 
minutes subsequently and drugs can be delivered through the SU-8 microtubes. Since the drugs 
are driven by pressure through microtubes in a continuous manner, the large molecular drug can 
also be delivered in an efficient way.  
 
Figure 2.1 13 Schematic illustration of the SU-8 microneedles. (a) Top view of the device structure. 
(b) A 5×5 SU-8 microneedles array. (c) Cross section of the device structure. (d) Single 
microneedle structure.   
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   An array of 5×5 SU-8 microtubes was patterned on a 140 µm thick, 2.5cm×2.5cm SU-8 
membrane (Figure 2.1 (a)). Each SU-8 microtube was 350 µm high. The inner diameter of the 
SU-8 microtube is 150 µm, while the outer diameter is 300 µm (Figure 2.1 (d)). Maltose needles 
of 1000 µm height were integrated on the SU-8 microtubes to ensure the ability of transdermal 
perforation. Two PDMS layers and the 2.5cm×2.5cm SU-8 membrane were bonded together to 
form a sealed chamber for retaining drugs from the connection tube during delivery process. The 
2.5cm×2.5cm size of the device was designed on purpose in order to conceptualize a flexible skin 
patch kind of drug delivery device. However, the critical area comprising the SU-8 microneedles 
at the center was only 6mm×6mm. The large marginal space offered sufficient area to achieve 
good bonding between SU-8 layer and PDMS layer, i.e., tolerating higher pressure to drive drugs 
into tissues during the delivery process. 
2.1.1.2 SU-8 Microtubes Fabrication  
    As shown in Figure 2.2, SU-8 microtubes fabrication started from a layer of Polyethylene 
Terephthalate (PET, 3M USA) film pasted on the Si substrate by sticking the edge area with kapton 
tape (Figure 2.2 (a)). The PET film, a kind of transparent film not sticky at the both side, was used 
as a sacrificial template to dry release the final device from the Si substrate because of the poor 
adhesion between PET film and SU-8. Before the dry releasing process, all the following SU-8 
processes would not make the device fall apart from the PET layer. Although in the work presented 
by Fernández et al [62], only the kapton film was used for the release purpose, we found that when 
the SU-8 patterned area on the kapton film was large, tearing off the film from the kapton film 
without damaging the device required extreme delicacy. This was because both the patterned SU-
8 layer and Si substrate were rigid layers. However, in our process, the sticky kapton film which 
just applied along the edges of samples could be easily removed after the device developed in SU-
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8 developer. The PET film with the SU-8 layer was separated from the Si substrate. Then SU-8 
layer could be dry released from the PET film just by slightly bending the PET film. 
 
Figure 2.2 14Fabrication process for SU-8 microtubes. 
A 140 µm thick SU-8 layer was deposited on the fixed PET film (Figure 2.2 (b)). To ensure a 
smooth SU-8 surface, this deposition was conducted in two steps of coating with 70 µm layer each. 
46 
 
In each step, SU-8 2050 was spun at 2000 rpm for 30 seconds, followed by prebaking steps at 
65 °C for 10 minutes and 95 °C for 30 minutes. After the prebaking steps, this SU-8 layer was 
exposed under 450 mJ/cm2 UV energy to define the membrane structure on this layer (Figure 2.2 
(c)). After exposure baking steps at 65 °C for 5 minutes and 95 °C for 15 minutes, another 350 µm 
SU-8 layer was directly deposited on this layer in two steps without development (Figure 2.2 (d)). 
If the first layer was developed to get patterns, the surface would not be smooth enough to achieve 
a uniform second SU-8 layer on it. With careful alignment (alignment accuracy is 20µm), an 
exposure of 650 mJ/cm2 energy was performed on the second layer to get the pattern of SU-8 
microtubes, which were precisely above the holes patterned on the first layer (Figure 2.2 (e)). 
After post exposure baking steps at 65 °C for 10 minutes and 95 °C for 30 minutes, then the SU-8 
device with PET film were released from the silicon substrate by the same method described before 
(Figure 2.2 (f, g)). After soaking in an ultrasonic cleaner for 30 minutes, the SU-8 microtubes 
array on the membrane was developed (Figure 2.2 (h)).  
2.1.1.3 PDMS Bonding 
   To bond the PDMS layer with SU-8, PDMS with mixing ratio of prepolymer base and curing 
agent in 10:1 was prepared firstly. After degassing, PDMS was cured and cut into small pieces. 
Then the first PDMS layer with square ring structure was treated with N2 plasma to introduce 
amino groups on one side. When this PDMS surface was contacted with the bottom side of SU-8 
surface having epoxy groups on surface, interfacial amine-epoxide chemical reaction took place 
at an elevated temperature. Therefore, after cured at 120 °C for 15 minutes, PDMS was 
permanently bonded with SU-8 layer.  
After the SU-8 membrane was released from the PET film, it bent during the developing process 
(Figure 2.3 (b)), due to residue stress gradients in SU-8 membrane. Here a homemade stage was 
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used to reduce this effect. As shown in Figure 2.3 (a), two akryl plates were applied to clamp SU-
8 membrane bonded with PDMS layer. Other two PDMS layers were used as soft buffer layers to 
protect the device. This stage offered a flat surface and uniform pressure on the SU-8 membrane. 
When put into the 120 °C oven, the SU-8 membrane will slightly deform because the bonded 
PDMS layer had a thermal expansion at this high temperature. Such effect relieved the previous 
bended layers and leads to a flatter surface (Figure 2.3 (c)). This flat surface was critical for the 
following maltose tips drawing process. Then oxygen plasma was performed on the opposite side 
of the first PDMS layer and one side of the second PDMS layer. After attaching these two surfaces 
together, two PDMS layers were bonded firmly together to form a fluidic chamber for the drug to 
flow into microtubes. 
 
Figure 2.3 15 (a) Schematic illustration of the homemade stage to ensure flat SU-8 membrane 
surface. (b) SU-8 membrane bends after development. (c) After bonded with PDMS and clamped 
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in the stage, the membrane becomes flat. 
2.1.1.4 Drawing Process of Maltose Tips 
    Maltose needles were integrated on the SU-8 microtubes by the drawing lithography technology. 
Lee et al encapsulated the drugs in maltose and patterned the maltose tips by drawing 
lithography[63]. Since the temperature in this method must be higher than 100 °C, a large group of 
drugs cannot stand at this temperature and will be degenerated. In our device, drugs will be 
delivered through SU-8 microtubes and the maltose is just used as sharp tips for skin penetration. 
Without facing the high temperature effect, our device is a generic platform to administer various 
kinds of drugs.  
 
Figure 2.4 16 Fabrication process for maltose tips. (a) Expelling water at 140 °C. (b) Immersing 
microtubes into the maltose at 140 °C. (c) Drawing the tips at end of the microtubes when the 
temperature increases up to 160 °C. (d) Increasing drawing speed to form sharp tips. 
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    As shown in Figure 2.4, fabrication of maltose tips on top of SU-8 microtubes was divided into 
four steps. First, concentrated maltose solution containing Methylene blue, which was used for a 
better inspection during penetration process, was dripped on a glass slide. The slide was kept at 
140 °C on the hotplate until the water inside maltose solution completely vaporizes and maltose 
becomes liquid state (Figure 2.4 (a)). Secondly, device of SU-8 microtubes was fixed on a 
precision stage which can control the position of SU-8 microtubes in three-dimension. Then we 
immersed the SU-8 microtubes into the liquid maltose at 140 °C and maltose liquid coated on the 
SU-8 microtubes’ surface (Figure 2.4 (b)). Thirdly, we gradually increased the temperature of 
liquid maltose and start drawing SU-8 microtubes away from interface of the liquid maltose and 
air (Figure 2.4 (c)). Finally, when the temperature rise up to 160 °C the drawing speed was 
increased. Since the maltose liquid was less viscous at higher temperature, the connection between 
the SU-8 microtubes and surface of the liquid maltose became individual maltose bridge and 
shrunk gradually, and then broke. The end of shrunk maltose bridge formed a sharp tip on top of 
each SU-8 microtube when the connection was collapsed (Figure 2.4 (d)).  Figure 2.5 showed the 
final drug delivery device containing SU-8 microtubes integrated with maltose tips and 
microfluidics, e.g. channels and the chamber formed by PDMS. 
 
Figure 2.5 17 Optical image for the finished SU-8 microneedles. (b) Detailed illustration image 
for the microneedles array. 
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2.1.2 Results and Discussion 
2.1.2.1 Optimization of Spacing Between Maltose Tips 
  To ensure the stronger and shorter maltose tips of a mircroneedle array for an easier skin 
penetration, experiments are conducted to optimize parameters in the drawing process. 
Temperature of melted maltose during drawing step and drawing speed are identified as the key 
parameters to get up to 1000 µm tall maltose sharp tips on the SU-8 microtubes. Although the 
maltose tip can be easily and routinely formed on top of SU-8 microtubes at 140 °C and optimized 
drawing speed, the formation of uniform maltose tips array also depends on the spacing between 
two adjacent SU-8 microtubes. 




Height of Microtubes 
Spacing Between two SU-8 Microtubes 
300µm 600µm 600µm 1200µm 
150μm 0/25 5/20 15/10 25/0 
250μm 0/25 13/12 21/4 25/0 
350μm 0/25 17/8 25/0 25/0 
 
   When the maltose melted at 140 °C, the planar extensional viscosity in maltose easily leads 
adjacent maltose tips to clusters. We have investigated various spacing between two adjacent 
maltose tips to get the minimum spacing. The height of microtubes changed from 150µm to 350 
µm with the interval of 100µm while the spacing changed from 300µm to 1200µm with the interval 
of 300µm. There were in total 12 different dimensions. Four chips were tested for each dimension 
as a group and the total trails were 48. Since there were 25 microneedles on each chip, there were 
in total 100 microneedles on 4 chips in each group. After the drawing process, the results for each 
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group were counted and converted as the ratio on a single 5×5 array for an average. Table 2.1 
showed the observed data about the ratio of formed individual maltose tips over the formed 
clustered tips in these 48 samples. We concluded that individual maltose tips were successfully 
derived from samples of microtubes with the height beyond 350µm and the spacing larger than 
900µm. As a result, we prepared many samples of SU-8 microtubes of 350µm height and 1000µm 
spacing for further maltose integration experiment in our study. 
2.1.2.2 Mechanical Strength of the Microneedles  
    To ensure both the adequate adhesion property between the maltose tip and SU-8 microtubes, 
and the sufficient stiffness of the SU-8 microtubes for successful penetration, the mechanical 
strength of microneedles was studied. As shown in Figure 2.6 (a), Instron Microtester 5848 
(Instron, USA) was used for the stiffness testing. A typical result was shown in Figure 2.6 (b). 
During the testing, the breakage of microneedles only occurred at the interface when the exerting 
load was larger than the threshold value. However, the SU-8 microtubes were strong enough to 
stand the pressure. After characterization of 20 samples, the average threshold value was 
7.36±0.48N for the microneedles (300µm at microneedle base and 1000µm high). Since the 
minimal force required for a successful penetration was reported to be less than 1 N with the similar 




Figure 2.6 18 (a) Testing setup for the microneedle mechanical testing. (b) A typical microneedle 
stiffness testing result 
2.1.2.3 Characterization of Penetration 
 
Figure 2.7 19 Penetration testing results on the porcine cadaver skin. 
    Figure 2.7 (a) shows the insertion result of a 5×5 microneedles array into a porcine cadaver 
skin. After the insertion, maltose tips were rapidly dissolved once inserted in the tissue. Methylene 
blue was added into the maltose for inspection purpose. Ten minutes after insertion, 25 blue traces 
were easily found, which matched the pattern of the microneedle array. The optical microscope 
image in Figure 2.7 (b) showed a hole perforated in the skin after we cleaned the dissolved maltose 
mixed with Methylene blue from the skin surface. During the insertion experiment, we had to 
avoid the shear force influence caused by deformed skin surface on the individual maltose tip in 
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order to get successful microneedle penetration for the whole array. We used precision stages to 
hold the microneedle device substrate and control the relative position of device substrate and skin 
sample.  
2.1.2.4 Dissolving of Maltose Tips and Demonstration of Injection via SU-8 Microtubes 
    
Figure 2.8 20 Maltose tips dissolving process. (a) The original sharp maltose tip. (b) Maltose tip 
after inserted into skin for 3minutes(c) 6minutes and (d) 9minutes.  
    In order to check whether the maltose tips could be dissolved once inserted in the tissue, four 
chips with the same maltose tips height were inserted into the skin and taken out one by one with 
3 minutes interval. Maltose tips were gradually dissolved versus increased time as shown in Figure 
2.8. After 9 minutes, the maltose tips were totally dissolved and the lumens of SU-8 microtubes 
were observed from the top view. Different from the traditional dissolvable needles which 
encapsulated drugs into the needles, this microneedle array was expected to allow large volume of 




Figure 2.9 21 Microfluidic testing for SU-8 microtubes. 
    Moreover, blue dyed water was ejected through the lumens in SU-8 microtubes to the beaker 
containing fresh water such that we could demonstrate the hollow tubes formed in individual 
microtube during the fabrication process. This microfluidic testing was performed in fresh water 
as shown in Figure 2.9. Visual inspection of the ejection proved that there was no blockage inside 
the microtubes. Because of the good bonding quality between each layer, there was no obvious 
damage on the device in this experiment even though the syringe pump was increased to its 
maximum speed at 3.3mL/min for 6mL syringe.  
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2.1.2.5 Injection Florescent Solution into Skin Sample 
 
Figure 2.1022 Images of confocal microscopy of the site where one microneedle inserted shows 
that the fluorescent solution is delivered into the tissue underneath the skin surface. Optical section 
depths are (a) 30μm, (b) 60μm, (c) 90μm, (d) 120μm, (e) 150 μm, (f) 180μm below the skin surface.  
    To verify that the drug solution can be delivered into tissue, a fluorescent solution was delivered 
through the SU-8 microtubes after the pure maltose tips were dissolved. The representative results 
were then investigated via a confocal microscopy (Figure 2.10). The permeation pattern of the 
solution along the microchannel confirms the solution delivery results. The black area served as a 
control area without any diffused solution. In contrast, the tissues stained by fluorescence 
illustrated the diffused area. The focus depth was up to 180µm with the interval of 30µm. Since 
the microchannel was created by the conical maltose tips, the diameter of the microchannel 
decreased as the focus depth increases. The following diffusion area was dependent on the 
microchannel dimension and also decreased accordingly.  
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2.2 Double Drawing Lithography Technology for Making Flexible Microneedle 
Patch with Lower Breakage Risk 
Even though the microneedles device with dissolving tips enables a large volume delivery of 
big molecular drugs, in practical experiments it is found that the planar shear force induced by skin 
deformation may break the microneedles device from the interface between SU-8 microtubes and 
maltose tips. In order to solve this problem, we propose an optimized design for the microneedles 
strucutre. The SU-8 microtubes are fabricated into beam stuctures. Gaps between these beams  act 
as anchors to reinforce the mechanical strength of the interfaces, which avoids microneedles 
beakage under planar shear force. The standard drawing lithography technology demonstrated 
before requires that the drawing frames need to be regular cylinders, which is not proper for our 
devices. To solve the problem, the optimized double drawing lithography is developed to create 
sharp SU-8 tips on the top of four SU-8 pillars for penetration purpose. Drugs can flow through 
the sidewall gaps between the pillars and enter into the tissues. 
2.2.1 Design and Fabrication 
    An array of 3×3 SU-8 supporting structures was patterned on a 140 µm thick, 6mm×6mm SU-
8 membrane (Figure 2.11 (a)). Each SU-8 supporting structure included four SU-8 pillars and was 
350 µm high. The four pillars were patterned into a tube like shape on the membrane (Figure 2.11 
(b)). The inner diameter of the tube was 150 µm, while the outer diameter was 300 µm. SU-8 
needles of 700 µm height were created on the top of SU-8 supporting structures to ensure the 
ability of transdermal perforation. Two PDMS layers were bonded with SU-8 membrane to form 
a sealed chamber for storing drugs from the connection tube. Once the microneedles penetrated 
into the tissue, drugs could be delivered into the body through the sidewall gaps between the pillars 




Figure 2.11 23 Schematic illustration of the SU-8 microneedles. (a) Overview of the whole device; 
(b) SU-8 supporting structures made of 4 SU-8 pillars; (c) Enlarged view of a single SU-8 
microneedle.  




Figure 2.12 24 Fabrication process for SU-8 microtubes. (a) Attaching a PET film on the Si 
substrate; (b) Exposing the first layer of SU-8 membrane without development; (c) Depositing and 
patterning two continuous SU-8 layers as sidewall pillars; (d) Releasing the SU-8 structure from 
the substrate and bonding it with PDMS; (e) Drawing hollowed microneedles on the top of 
supporting structures; (f) Baking and melting the hollowed microneedles to allow the SU-8 flow 




 The fabrication process of SU-8 microneedles is shown in Figure 2.12.  The SU-8 
supporting structure is fabricated as the same method of SU-8 microtubes fabrication shown before 
(Figure 2.12 (a)-(c)). However, since the frame used to conduct drawing process in present study 
is a four-pillars structure rather than a microtube, the conventional drawing process can only make 
a hollowed tip but not a solid tip structure (Figure 2.13). This kind of tip was fragile and could not 
penetrate skin in practical testing process. To solve the problem, we developed an innovative 
double drawing lithography process. After bonding released SU-8 structure with PDMS layers 
(Figure 2.12 (d)), we used it to conduct first time stepwise controlled drawing lithography and got 
hollowed tips (Figure 2.12 (e)). After the hollowed tips were formed in the first step drawing 
process, the whole device was baked on the hotplate to melt the hollowed SU-8 tips. Melted SU-8 
reflowed into the gaps between four pillars and the tips became domes (F Figure 2.12 (f)).     
 
Figure 2.13 25 A hollowed SU-8 microneedle fabricated by single drawing lithography technology 
(Scale bar is 100 µm). 
Then a second drawing process was conducted on the top of melted SU-8 to form sharp and solid 




Figure 2.14 26 Optical images for the SU-8 microneedle patch. 
2.2.2 Characterization for Microneedles Fabricated by Double Drawing Lithography Technology 
    During the double drawing process, as long as the heated time and temperature were controlled, 
the SU-8 flow-in speed of SU-8 inside the gaps could be precisely determined.  The relationship 
between baking temperature and flow-in speed was studied. As shown in Figure 2.15, the flow-in 
speed is positive related to the baking temperature. The explanation for this phenomena is that the 
SU-8’s   viscosity decreases when the baking temperature increases. When the baking temperature 
is larger than 120 °C, the flow-in speed will increase sharply. But if the baking temperature is 
higher, the SU-8 will reflow in the gaps too fast, which makes the flow-in depth hard to be 
controlled. There is a high chance that the whole gaps will be blocked and no drugs can flow 
through these gaps any more. Considering that the total SU-8 supporting structure is only 350 µm 
high, we choose 125 °C as baking temperature for proper SU-8 flow-in speed and easier SU-8 
flow-in depth control.   
   To ensure the adequate stiffness of the SU-8 microneedles in vertical direction, mechanical 
testing was conducted as described before. As shown in Figure 2.16, the vertical buckling force 
was as much as 8.1N, which was much larger than the reported minimal required penetration force. 
However, in previous practical testing experiments, even though the microneedles were strong 
enough in vertical direction, the planar shear force induced by skin deformation might also break 
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the interface between SU-8 pillars and top tips. In our new device with four pillars supporting 
structure, the SU-8 could flow inside the sidewall gaps between the 
pillars to form anchors. These anchors could enhance microneedles’ mechanical  strength and 
overcome the planar shear force problems. Moreover, the anchors strength could be improved by 
controlling the SU-8 flow-in depth. Figure 2.17 shows that the flow-in depth increases when the 
baking time increases as the baking time increases at 125 °C. The corresponding planar buckling 
force can be improved to be larger than 1 N by increasing flow-in depth (Figure 2.16 (b)). Some 
spacing in sidewall gaps at bottom is kept on purpose for drugs flow, hence the flow-in depth is 
chosen as 200 µm. 
 




Figure 2.16 28 (a) Measurement of the vertical buckling force. (b) The planar buckling force 





Figure 2.17 29 Different flow-in depth inside the gaps between SU-8 pillars. (a) 0 µm; (b) 100 
µm; (c) 200 µm; (d) 350 µm (Scale bar is 100 µm).  
The penetration capability of the SU-8 microneedles is also characterized by conducting 
the insertion experiment at porcine cadaver skin. 10 microneedles devices were tested and all of 
them were strong enough to be inserted into the tissue without any breakage. Histology images of 
the skin at the site of one microneedle penetration were derived to prove that the sharp conical tip 
was not broken during the insertion process (Figure 2.18). It also shows penetration evidence 
because the shape of the microchannel is the same as the sharp conical tip. 
 
Figure 2.18 30 Histology image of individual microneedle penetration (Scale bar is 100 µm). 
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Due to the uneven surface of deformed skin, there is always tiny gap happened between 
tips of some microneedles and local surface skin. The microneedles could not be entirely inserted 
into the tissue. Drugs might leak to the skin surface through the sidewall gaps under certain driven 
pressure. Hydrogel absorption experiment was conducted to quantify the delivery rate (i.e., the 
ratio of solution delivered into tissues in the total delivered volume) and to optimize the delivery 
speed. Gelatin hydrogel was prepared by boiling 70 mL DI (Deionized) water and mixing it with 
7g of KnoxTM original unflavored gelatin powder. The solution was poured into petri dish to 1cm 
high. Then the petri dish was put into a fridge for half an hour. Gelatin solution became collagen 
slabs. The collagen slabs were cut into 6mm×6mm sections. A piece of fully stretched Parafilm 
(Parafilm M, USA) was tightly mounted on the surface of the collagen slabs. This parafilm was 
used here to block the leaked solution further diffused into the collagen slab in the delivery process. 
Then the microneedles were penetrated the parafilm and went into the collagen slab. Controlled 
by a syringe pump, 0.1 mL 0.5mg/mL glucose solution was delivered into the collagen slab under 
different speeds. Methylene Blue (Sigma Aldrich, Singapore) was mixed into the solution for 
better inspection purpose (Figure 2.19 (a)).  Then the collagen slabs were digested in 1mg/mL 
collagenase (Sigma Aldrich, Singapore) at room temperature (Figure 2.19 (b)). It took around 1h 
that all the collagen slabs could be fully digested (Figure 2.19 (d)). 
The solution was collected to measure the glucose concentration with Glucose  Detection kit 
(Abcam, Singapore). Briefly, both diluted glucose standard solution and the collected glucose 
solution were added into a series of wells in a well plate. Glucose assay buffer, glucose enzyme 
and glucose substrate were mixed with these samples in the wells. After incubation for 30 minutes, 
their absorbance were examined by using a microplate reader at a wavelength of 450nm. By 
comparing the readings with the measured concentration standard curve (Figure 2.20 (a)), the 
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glucose concentration in the hydrogel, the glucose absorption rate in the hydrogel and the solution 
delivery rate by microneedles could be measured and calculated. As shown in Figure 2.20 (b), 
when the delivering speed for a single microneedle increased from 0.0001mL/min to 0.002mL/min, 
the glucose absorption rate also increased. Most of the glucose solution from microneedles could 
go into the hydrogel. The delivered rate could be as high as 71%. The rest solution leaked from 
sidewall gaps and blocked by parafilm. However, when the delivered speed for a single 
microneedle was larger than 0.002mL/min, the hydrogel absorption rate was saturated. More and 
more solution could not go into the hydrogel but leak from the sidewall gaps. Then the delivered 
rate decreased. Therefore, 0.002ml/min was chosen as the optimized delivery speed for the 
microneedle. However, due to the nature of transdermal drug delivery which the drug is not 
directly injected into the vein, the absorption rate of skin will has a certain limitation. Currently 
the maximum skin absorption rate by microneedle is 16mg/day[143] by a microneedle array of 
480 microneedles. Thus the maximum delivery rate of each microneedle should be around 
33µg/day. Considering the density of the drug solution will be quite close to the density of water, 
thus the maximum delivery rate for an individual microneedle should be 0.023µL/min.  Thus the 
maximum deliver rate of the microneedle we fabricated is far more than the maximum absorption 




Figure 2.19 31 Glucose solution could be delivered into the hydrogel and the collagen stabs were 




Figure 2.20 32  (a) Standard curve for glucose detection; (b) Glucose absorption rate and 
solution delivery rate in a single needle corresponding to different delivery speed.  
2.3 Conclusion 
Based on the drawing lithography technology, we designed and developed two different kinds 
of flexible microneedle patches. Both of them are hollow microneedles which can be used for the 
delivery of drugs with big molecules. The flexible microneedle patch with dissolvable sharp tips 
is able to deliver drugs with large volume while four beams structure with SU-8 tips enhance the 
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microneedle stiffness. The proposed fabrication process is scalable, reproducible and inexpensive. 
Penetration testing and diffusion testing prove their function to deliver drugs to the tissues under 
the skin. In the hydrogel absorption experiment, by controlling the delivery speed under 




Chapter 3 Polymer Microneedle Array Integrated with 
CNT Nanofilter for Selective Drug Delivery 
 
Currently none of microneedles developed have integrated functions for controlled drug release 
with mechanical valves such as CNT nanofilters. However, such a drug control releasing function 
is desirable for long term drug delivery and could expand the applications of microneedles. In this 
chapter, a unique process which utilizes a membrane based vertically grown carbon nanotubes 
(CNTs) as nanofilters for mass transport study is presented first. By leveraging the double drawing 
lithography process, the CNT nanofilters are integrated with the SU-8 microneedles. With the 
CNTs nanofilters, the delivery of drugs of different molecular dimensions could be controlled by 
pressure and an electric field. 
The design of the microneedle array integrated with CNT nanofilters is shown in Figure 3.1. 
An array of SU-8 microneedles was patterned above a SU-8 membrane(Figure 3.1 (a)). Every SU-
8 microneedle has two parts: four-beam sidewalls at the bottom and a sharp tip at top as shown in 
Figure 3.1 (c). The four-beam sidewalls (brown parts in Figure 3.1 (a)) are patterned by photo 
lithography. The gaps along the sidewalls are the outlets of the microneedles. The sharp tips above 
the four-beam structure (green parts in Figure 3.1 (a)) are assembled and patterned by double 
drawing lithography. Above them, a layer of gold surface electrode was deposited onto the whole 
surface. This surface electrode allows us to apply an electric field in the test. Inside the four-beam 
structures, vertical grown CNT bundles (black parts in Figure 3.1 (a)) were embedded in the SU-
8 membrane to form the CNT nanofilters. Fig. 1(d) shows the SEM image of one CNT bundle. 
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Underneath the SU-8 membrane, there a SU-8 chamber layer to support the SU-8 membrane layer 
and form a solution chamber. PDMS layers (the blue part in Figure 3.1 (a)) are bonded to the SU-
8 chamber layer for tube connection in the test. Solution could be loaded in the chamber under the 
CNT bundles, pass through the CNT bundles and finally through the SU-8 microneedles into the 
tissue. The optical image of the microneedle array with the gold surface electrode is shown in 
Figure 3.1 (b). For applying the electric field across the CNT nanofilters in the test, one electrode 
will be bonded onto the surface electrode and another electrode will be inserted into the PDMS 
chamber as shown in Figure 3.2. When the solution is loaded in the drug reservoir and flow 
through the CNT nanofilters, two electrodes would be connected by the solution and an electric 
field is generated across the CNT nanofilters. 
Before the integration of microneedle with CNT nanofilters, we made a detailed study and 





Figure 3.1 33  (a) 3D schematic drawing of the microneedle device integrated with CNT 
nanofilters; (b) Optical image of the microneedle array with gold surface electrode, scale bar is 
1000μm; (c) SEM image of single SU-8 microneedle with four-beam sidewalls and a sharp tip, 






Figure 3.2 34 Working principle of the microneedle array integrated with CNT nanofilters for 
transdermal drug delivery. 
3.1 Development of CNTs Nanofilters Using Patterned Array of Vertically Grown Carbon 
Nanotubes  
3.1.1 Structure and fabrication process of the CNTs nanofilters 
Figure 3.4 shows the experimental steps for the fabrication of membrane based nanofilters 
shown in Figure 3.3 using patterned CNT bundles. A substrate with arrays of vertically aligned 
CNTs  patterns (Figure 3.5 (a)) is first reinforced by CVD grown parylene (Scheme 1,step 1) so 
that parylene molecules are infiltrated into the intertube space (Figure 3.5 (b)). The parylene layer 
together with patterned CNTs array is then peeled off from the substrate and the catalyst layer on 
the backside is etched off by oxygen plasma (Scheme 1, step 2).  The backside catalyst layer is 
shown in Figure 3.5 (c). After oxygen plasma, the catalyst layer is etched away (Figure 3.5 (d)). 
The released parylene layer is then attached to a prebaked SU-8 substrate. The Su-8 substrate is 
baked and cooled to achieve the bonding with parylene (Figure 3.4, step 3). Vertical microfluidic 
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channels under CNTs bundles shown in Figure 3.5 (b) are patterned by stand lithography (Figure 
3.4, step 4). The bottom side of the CNTs bundle is open. The top side of the CNTs bundles are 
open by oxygen plasma etching (Figure 3.4, step 5).  Figure 3.4 (d) shows the CNTs bundle with 
top open. Figure 3.4 (e) shows the 3D schematic drawing of the open CNTs bundle for a better 
understanding. The whole parylene layer is etched off due to no mask in the etching process. The 
parylene sidewall is remained due to the anisotropic property of plasma etching. These parylene 
sidewalls provide the bonding which make the CNTs bundles be fixed onto SU-8 substrate. Two 
PDMS layers are further bonded at the bottom of the device for tubing and tests (Figure 3.4 (a) 
and (b)).  The detailed fabrication process can be found in Appendix 1. 
 The bonding strength between parylene and SU-8 is very strong. The detachment between 
parylene and substrate[1] will not occur here. Because of that we use CNT bundles of small patterns 
instead of whole CNT forests of large area, the CNT forests will not break by applying pressure. 






Figure 3.3 35 (a) 3D schematic drawing of detailed layer structure of the devices.; (b) SEM picture 
taken from the back side of the SU-8 layer showing a hole under a CNTs bundle on SU-8 layer. (c) 
3D Schematic drawing of the device (d). SEM picture of the CNTs bundle with top end open; (e) 






Figure 3.4 36 Schematic representation of the experimental steps showing the fabrication of 
membrane based nanofilters. 
 
Figure 3.5 37 (a) An individual CNTs bundle grows from catalyst layer, the diameter of the CNTs 
bundle is 50 μm, the height of the CNTs bundle is 50 μm; (b) An individual CNTs bundle reinforced 
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by parylene, the thickness of the parylene layer is 10 μm; (c) catalyst layer seals the bottom of the 
CNTs bundle; (d) The catalyst layer is etched by oxygen plasma; (e) TEM picture showing the 
inner diameter of the CNTs is 10 nm; the scale bars for (a) to (d) are 10 um and the scale bar for 
(e) is 10nm. 
 
3.1.2 Characterization of CNTs nanofilters 
3.1.2.1 Ions transport test 
The mass transport of ions and biomolecules of nanofilter samples of different dimension is 
measured by applying electric field and pressure based on the test setup in Figure 3.6 (a). 
A Ti electrode penetrated the PDMS layer and connected the solution inside the PDMS chamber. 
Bias could be applied via this electrode.  Test solution of very small volume was pre-loaded in the 
device chamber and part of the tube. This preloading is necessary to get rid of the air in the device 
chamber and make the solution in touch with the surface of CNTs bundles. The tube connected 
the device with a syringe and a pressure sensor. The syringe could be driven by a syringe pump to 
give air pressure and the air pressure is calibrated by the pressure senor. 
Based on our observation, the CNTs nanofilters are able to sustain under a pressure level of 
40kPa, but for some samples, leakage between the interface of PDMS and SU-8 was detected at a 
pressure level higher than 25kPa. Thus, the pressure level was limited within 25kPa in our 
experiments. The device was loaded in the beaker. The liquid surface in the beaker should be kept 
lower than the exposed part of the electrode inserted in PDMS. This was to avoid the two electrodes 
being shorted by the solution connection. Another Ti electrode was immersed in the solution in 
the beaker. 
The two electrodes were connected to a semiconductor characterization system (KEITHLEY 
4200) which could apply bias and measure the current simultaneously. Resultant solution was 




Figure 3.638 Test setup for applying electric field and pressure; (b) Schematic drawing of the 
ion diffusion and ion depletion in the device chamber. 
 
Figure 3.7 39 (a) The ionic current through the CNTs membranes as a function of time in different 
NaCl concentrations; (b) The ionic current as a function of time under square wave bias in different 
NaCl concentrations . The green line and pink line indicate the difference between peak values of 
ionic current. (c) The pH value of the NaCl solution with different concentrations as a function of 
time; (d) The pH value of the HCl solution under different driving pressure as a function of time. 
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In the study of driving ions by electric field, NaCl solution was loaded in both the beaker and 
the tube. The solution volume in the beaker was 60 ml and in the tube was about 0.2 ml. A bias of 
5 V was applied between the two Ti electrodes for 160 min. The electrode in the beaker was 
grounded and the electrode in the tube was positively biased. No air pressure is applied. No obvious 
electrolysis of water is observed. Two concentrations of NaCl solution, 1mol/L and 0.1mol/L, were 
employed to study the relation between the ion concentration and ionic current. The experiments 
were carried out at room temperature (~26ºC). The solution in beaker was sampled for pH 
measurement at 10, 20, 40, 80 and 160 min. The change of ionic current was recorded as shown 
in Figure 3.7 (a). The ionic current quick dropped down as a function of time. The peak values of 
the ionic current of NaCl concentration 0.1 mol/L and 1mol/L were 9.5×10-5A and 2.4×10-5A. The 
large peak value difference suggests that the main transport mechanism under electric field is 
electrophoresis[66]. The drop of the ionic current may due to two possible reasons. First, the change 
of pH value altered the property of the CNTs inner wall surface which enhanced the interaction 
between ions and CNTs inner wall surface. This pH value change was caused by electrolysis of 
NaCl solution. The reaction in beaker is : 
2NaCl+2H2O+2e-→2NaOH + H2↑+2Cl-; 
so the solution will be alkaline and pH value will rise. And the reaction in the tube is: 
2NaCl+2H2O→2Na++HCl+HOCl+2e-; 
so the solution will be acidic and pH value will drop. The change of the pH value is shown in 
Figure 3.7 (c). The NaCl solution of higher concentration had a higher pH value which means a 
faster reaction rate. And the difference of pH value inside the beaker and tube increased with time. 
However, according to Figure 3.7 (a), the ionic current tends to stabilize with time. So the change 
of the pH value should not be the reason for the drop of ionic current. It is also reported that the 
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pH value of the solution does not significantly affect the ionic current and the conductance of 
CNTs[65]. The second possible reason is the depletion of the ions at the PDMS chamber. The high 
peak values of the ionic currents stand for fast ion transport. This fast ion transport may cause 
depletions which cannot be compensated by the ion diffusion from other regions. As shown in 
Figure 3.6 (b), the geometry of device chamber connecting to the CNTs bundles is very limited. 
One possible reason is that ions cannot efficiently diffuse from other places to this region when 
ions at this region quickly pass through the CNTs bundles. Then the depletion of the ion in the 
DPMS chamber causes the drop of the ionic current. We carried out an experiment to prove it. The 
5 V bias was applied in a square wave mode with duty cycle of 1 min on and 1 min off. This square 
wave mode bias was applied for several cycles and the recorded ionic current is shown in Figure 
3.7 (b). The ionic current dropped when bias was on. When bias was not off, the solution in the 
device chamber got replenishment of ions by the diffusion from other regions. Thus, when bias 
was on again, the peak value of ionic current recovered to a certain level. But due to 1 min time 
duration was insufficient for the recovery of ion concentration in the device chamber to its initial 
value, the peak value of ionic current still had a slightly drop. The green line shows the drop of 
peak values  from about 1.5×10-5A to about 1.4×10-5A  for 1mol/L NaCl concentration. 
In the study of driving ions by pressure, 0.2 ml 3.7% HCl solution was preloaded in the tube. 60 
ml DI water was loaded in the beaker. Air pressure of 10kPa and 20kPa was applied for 80 min to 
study the relation between pressure and permeability with a zero biasing voltage. Solution in the 
beaker was sampled at 10, 20, 40 and 80 min. The pH value of solution samples was measured by 
pH meter (CORNING Pinnacle, Model: 530) as shown in Figure 3.7 (d). The line of 20kPa 
pressure shows a greater pH value drop than that of 10kPa. At 80 min, the pH values of solution 
after applying 10kPa and 20kPa were 4.25 and 3.97. According to the definition of pH value: 
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pH=-log[H+]; ([H+] refers to the H+ concentration.) 
The ratio of H+ concentration is [H+]20kPa/[H+]10kPa =104.25/103.97=1.9. The ratio of H+ 
concentration was almost the same as the ratio of pressure level. This result suggests a linear 
relation between mass transport rate and pressure level, which is consistent with result reported[65]. 
3.1.2.2 Bio-molecules transport test 
In the study of large molecule translocation through CNTs membrane, ss-DNA and 
Haemagglutinin were employed to study CNTs bundles' function of filter. The inner diameter of 
the CNTs in this study is 10 nm (Figure 3.5 (e)). The ss-DNA whose cross sectional dimension is 
smaller than 10nm was expected to pass through CNTs membranes just by applying pressures. 
And Haemagglutinin, whose shape is like a cylinder and dimension is approximately 13.5 nm long 
that are larger than the inner diameter of the CNTs, was expected not to pass through CNTs 
membranes by applying pressure. The preparation of ss-DNA can be found in Appendix 2. 
A medley of pressure and electric field driven method could drive ss-DNA through CNTs is 
reported[66]. In the experiment of ss-DNA, 60 ml DI water was loaded in the beaker, a droplet of 
ss-DNA solution was preloaded in the tube. Pressure of 25 kPa was applied for 7 hours. The 
solution in the beaker was sampled after the experiment. The absorbance spectra were shown by 
FTIR (Fourier transform infrared spectroscopy Cary 660-FT-IR). DI water was used as 
background to show the absorbance in Figure 3.8 (a). The green line shows that ss-DNA could 
pass through CNTs membranes just by applying pressure. The absorbance shown in Figure 3.8 
(a) suggests that more ss-DNA could pass through CNTs by the additional electric field. 
 In the case of Haemagglutinin under pressure driven condition, no absorbance observed in 
spectra of samples carried out at applied pressure of 10, 15 and 20kPa for 7 hours. Figure 3.8 (b) 
shows the measured spectrum under 25 kPa for the above samples with additional 15 hours. Again 
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there is no absorbance observed. Then a pressure level of 25kPa and a bias of 5V was applied 
together. The measured spectrum indicates a weak absorbance as shown in Figure 3.8 (b). It 
suggests that Haemagglutinin could pass through CNTs when pressure and electric field were 
applied together. But the translocation rate was relatively low compared to that of ss-DNA. This 
is because the dimension of Haemagglutinin is much larger than that of ss-DNA. The test result 
shows that permeability decreases with the increase of dimension of molecule. 
To confirm CNTs nanofilters could block all the micro-scale substance, we further tried passing 
bacterium through CNTs nanofilters. In this experiment, PBS and BPSM (Bordetella pertussis, 
streptomycin resistant) are employed. The test setup is as shown in Figure 3.6 (a). 0.1 ml mixed 
solution was loaded in the device and PBS was loaded in the beaker. A medley of pressure and 
electric field driven method was used to drive the PBS through the CNTs nanofilters. The pressure 
is 20kPa and the electric bias is 5V. To detect the bacterium of very low concentration, the solution 
should be sampled for cell culture and enrichment. To ensure the bacterium were viable in ambient 
temperature during the experiment, the test was conducted for 2 hours. The solution sampled in 
the beaker was cultured on blood agar plates for 5 days to see whether bacteria passed through the 
CNTs nanofilters. Solution with bacteria loaded in the device chamber was also cultured as control 
group for comparison. Figure 3.9 (a) shows the result of bacterial culture of the solution sampled 
from the device chamber. After 5 days of culture, bacterial colonies were observed. Figure 3.9 (b) 
shows the result of bacterial culture of the solution sampled in the beaker. No bacterial colony was 




Figure 3.840  (a) IR spectra of ss-DNA in the beaker after applying 25kPa pressure and after 
applying both 25kPa pressure and 5V bias; (b) IR spectra of Haemagglutinin in the beaker after 
applying 25kPa pressure and after applying both 25kPa pressure and 5V bias. 
 
 
Figure 3.9 41 (a) Result of bacterium culture of the solution sampled from the device chamber, 
bacterial colonies were observed; (b) Result of bacterium culture of the solution loaded in the 
beaker, no bacterial colony was found. 
In conclusion, we propose a new fabrication process for a stretchable membrane based 
nanofilters using patterned array of vertically grown carbon nanotubes bundles. The functionality 
is proved by pumping ions through CNTs membranes either by applying pressure or applying 
electric field. A linear relation between mass transport rate and driving pressure is observed. The 
ss-DNA could pass through the CNTs membranes by applying high pressure and an additional 
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electric field can further enhance the permeability. However, Haemagglutinin whose dimension is 
close to the inner diameter of the CNTs cannot pass through the CNTs membranes just by applying 
pressure but an additional electric field could make it pass through. It proves that the permeability 
through CNTs nanofilters is highly dependent on molecular weight and physical dimension. 
Micro-scale bacterium would be totally blocked which confirms device’s high quality and 
reliability. The test results prove that the CNTs membranes could be deployed as nanofilters 
working at high pressure which is not reported yet. The CNTs nanofilters of patterned CNTs 
bundles on the flexible polymer materials enable a further integration with other microfluidics for 
chemical and pharmaceutical applications. These results also indicate the device could be used for 
size matching molecular sieving. Just by using the same process on CNTs of different inner 
diameters, the devices could be used for different kinds of chemical separation. It is also possible 
to involve surface functionalization to enhance the capability of chemical separation. 
3.2 Integration between Microneedle and CNTs nanofilters for selective drug delivery 
3.2.1 Fabrication process 
 Figure 3.10 illustrates the fabrication process. The process began with thermal oxidation 
of single crystal silicon substrate to form a etch stop oxide layer. After the CVD of polycrystalline 
silicon as a sacrificial layer, a 5 nm thickness of Fe film, which acted as the catalyst film for the 
selective growth of CNTs, was patterned onto the silicon substrate (Figure 3.10(a)). As illustrated 
in Figure 3.10(b), the vertical aligned CNT bundles of 50 μm in height were grown via pyrolysis 
of acetylene at 800ºC with an Ar/NH3 flow for 15 min. As illustrated in Figure 3.10(c), the CVD 
parylene-C was employed to fill into vertically aligned CNTs and then to reinforce the inter-tube 
binding at room temperature. Thus, the top side of CNTs was covered with parylene-C, and the 
discrete CNTs were bound together by parylene-C as show in Figure 3.11(a). This step was the 
most critical process for forming the mechanical supporting layer for CNT bundles. The thickness 
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of the flexible parylene-C layer was determined by the CVD process. To achieve reliable 
mechanical strength for the following process, a 10 μm thick parylene layer was deployed. The 
parylene layer was peeled off together with CNT bundles from the substrate. As shown in Figure 
3.10(d), the parylene film was attached onto a thin glass slide. Then a layer of 50μm SU-8 was 
deposited onto the parylene layer. The thickness of this SU-8 layer was the same as the height of 
CNT bundles. Due to the transparency of the glass slide and parylene layer, the SU-8 layer was 
exposed from the back side of the glass slide. The catalyst layer under the CNT bundles could act 
as mask in this lithography step. The SU-8 above the CNT bundles would not be exposed. After 
development of SU-8, the parylene top of CNT bundles would not be covered by SU-8 as shown 
in Figure 3.10(e) and Figure 3.11(b). Such a SU-8 layer deposited above the parylene layer could 
act as hard mask for plasma etching. The sealed parylene top of CNT bundles could be etched by 
oxygen plasma as shown in Figure 3.10(f) and Figure 3.11(c). Then the parylene layer was 
released together with the SU-8 cover layer from the glass slide and bonded onto an unexposed 
SU-8 layer deposited on another thin glass slide as shown in Figure 3.10(g). In this process, a 
layer of SU-8 was spin coated and pre-baked on a thin glass slide first. After cooling, the released 
parylene layer was attached onto the SU8 layer then re-bake the SU-8 layer to make it molten. 
After cooling, a good bonding was formed between the parylene layer and the SU-8 layer. The 
sample was exposed from the backside of the glass slide to form a drug reservoir under the parylene 
layer as shown in Figure 3.10(h). The size of the drug reservoir should be slightly larger than the 
dimension of the CNT bundle array. The catalyst layer at the backside of CNT bundles was etched 
off by oxygen plasma and a thin PDMS layer was bonded at the backside as shown in Figure 
3.10(i). For the bonding between PDMS and SU-8, the PDMS layer should be treated with nitrogen 
plasma then be attached onto the SU-8 layer and baked at 120ºC for 30 minutes. Then a 30μm 
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thick SU-8 membrane was patterned on the front layer of sample as shown in Figure 3.10(j) to 
reinforce the structure. On this membrane layer, holes aligned with the CNT bundle array were 
patterned. As shown in Figure 3.10(k), array of SU-8 four-beam sidewalls array was further 
aligned and patterned above the membrane layer. As shown in Figure 3.10 (i), a thick PDMS layer 
with a center hole was bonded at the backside. This PDMS layer was used for tubing purpose. The 
center hole was for the insertion of the tube. Then SU-8 sharp tips were assembled onto the four-
beam sidewalls array by double drawing lithography as shown in Figure 3.10 (m). Finally, a gold 
surface electrode was deposited onto the whole surface by evaporation as shown in Figure 3.10 
(n). The detailed structure of a single microneedle integrated with a CNT nanofilter is shown in 





Figure 3.1042 Fabrication process for microneedle array integrated with CNT nanofilters: (a) 
Pattern Fe catalyst layer; (b) Grow vertical CNT bundles; (c) Reinforce the CNT with parylene 
and dry release; (d) Attach the released sample onto a glass slide; (e) Deposit a layer of SU-8 and 
expose from backside; (f) Dry release the sample from glass slide; (g) Bond the release sample 
onto an unexposed SU-8 deposited on a glass slide; (h) Expose from backside to form the drug 
reservoir; (i) Bond a thin PDMS layer with a large central hole at the backside of the sample; (j) 
Pattern a SU-8 membrane layer to reinforce the sample; (k) Pattern a SU-8 four-beam array aligned 
to the CNT bundle array; (l) Bond a thick PDMS layer with a central hole at the backside; (m) 
Assemble the microneedle array by double drawing lithography; (n)deposit a gold layer onto the 






Figure 3.1143 (a) CNT bundle coated with parylene, the scale bar is 10μm; (b) CNT bundle with 
parylene top embedded in SU-8 layer, the scale bar is 10μm; (c)CNT bundle embedded in SU-8 
layer after oxygen plasma etching, the scale bar is 10μm. 
3.2.2 Characterization of CNT nanofilters within microneedles 
In the fabrication process, the both ends of CNT bundle need to be opened by oxygen 
plasma. Initially the bottom end of CNT bundle is sealed by Fe catalyst layer. Fig 5(a) shows the 
exposed CNTs at the bottom side after oxygen plasma treatment. The infiltration depth of the 
parylene by CVD is limited by the nano-scale gap between the individual CNTs, the inner part of 
the CNT bundle cannot be reinforced by parylene. Thus there is no parylene at the central bottom 
area of the CNT bundles. Fig 5(b) shows the detailed image of the exposed CNTs at the bottom 
end of a CNT bundle after oxygen plasma etching. There is no parylene between the CNTs.  
In the process of etching the top parylene layer, the proper dose of oxygen plasma is critical 
to make the CNTs exposed. Figure 3. 12 (c) shows the top of CNT bundle with the proper dose of 
oxygen plasma. Figure 3. 12 (d) shows the detailed image of the exposed CNTs. In the images, 
tops of individual CNTs could be seen embedded within the parylene reinforcement. No cracks 
between CNT and parylene were observed. The SU-8 layer around the CNT bundle was very rough 
after the oxygen plasma etching. Figure 3. 12 (e) shows the CNT bundles with the over dose 
oxygen plasma treatment. The CNTs were fully exposed and the parylene between CNTs are 
totally etched off. The connection between CNT bundles and parylene sidewalls became very weak. 
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By applying an air pressure from the backside, the whole CNT bundle would be blown away as 
shown in Figure 3. 12 (f). To ensure the CNT bundles are etched with the proper dose of oxygen 
plasma, the whole etching process was divided into several cycles. The samples were checked by 
SEM after every cycle until only the tops of CNTs were exposed as shown in Figure 3. 12 (d). 
 
Figure 3.12 44 Backside of the CNT bundle. The catalyst layer is etched by oxygen plasma. The 
scale bar is 10μm. (b) The detailed image of the backside exposed CNTs. The scale bar is 2μm. (c) 
Top of the CNT bundle with proper etching dose. The scale bar is 20μm. (d) The detailed image 
of the top exposed CNT. The scale bar is 2μm. (e) Top of the CNT bundle with over etching dose. 
The scale bar is 20μm. (f) After applying an air pressure, the CNT bundle within the parylene 
sidewall is blown away. The scale bar is 20μm. 
3.2.3 Nanoparticles blockage test 
By having the CNT nanofilters, nano-scale substance whose dimension is larger than the inner 
diameter of the CNT nanotube should be blocked. However, micro-scale and nano-scale cracks 
may occur in the parylene reinforced CNT bundles which will cause the device failure. It is 
necessary to verify there is no crack in the CNT nanofilters device. Because the whole device is 
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made of polymer which is not suitable for TEM imaging, we leveraged fluorescent nanobeads to 
confirm whether the samples were crack free or not in this study. 
Texas red (Sigma Aldrich, Singapore) whose molecular weight is 606.71 and fluorescent 
nanobead (Sigma Aldrich, Singapore) whose dimension is 80nm were mixed and delivered into 
the mouse skin by the microneedle devices with and without CNT nanofilters. The fluorescent 
images are shown in Figure 3. 13. For the device without CNT nanofilters, both Texas red and 
fluorescent nanobeads are delivered into skin as shown in Figure 3. 13 (a). The color of the mixed 
fluorescent is violet. For the device with CNT nanofilters, the skin shows red color rather than 
violet as shown in Figure 3. 13 (b), which indicates only Texas red is delivered and fluorescent 
nanobeads are blocked. The results confirm that the CNT nanofilters could block nanobeads and 
there was no nano-scale crack in the CNT nanofilters. On the other hand, it has been reported that 
out-of-plane microneedles are not able to be inserted entirely into the skin [67-69]. During the process 
of delivering drug into the skin, we found that there were micrometer scale tiny gaps between 
bottom edge of each microneedle and skin surface due to the skin deformation as depicted in 
Figure 3. 13 (c). The concave skin surface around the edge of microneedle sidewall leaves a tiny 
gap at bottom part of microneedles. To investigate efficacy of microneedles in delivering drug 
even with the existence of these micrometer scale gaps, hydrogel absorption experiments were 






Figure 3.13 45 Fluorescent images of mouse skin: (a) Texas red and nano-fluorescent beads are 
delivered with microneedle device without CNT nanofilters; (b) Texas red and nano-fluorescent 
beads are delivered with microneedle device with CNT nanofilters; (c) The micrometer scale gaps 
occur between skin and bottom edge of a microneedle due to skin deformation. 
3.2.4 In Vitro Drug Delivery Test 
Gelatin hydrogel was prepared by boiling 70 mL DI (Deionized) water and mixing it with 
7g of gelatin powder (KnoxTM original unflavored). After cooling down, the solution was poured 
into a petri dish to 1cm high. Then the petri dish was put into a fridge for half an hour. The Gelatin 
solution became collagen slabs. The collagen slabs were cut into 6mm×6mm sections. A piece of 
fully stretched Parafilm (Parafilm M, USA) was tightly mounted on the surface of the collagen 
slabs. This parafilm was used here to block further diffusion of leaked solution into the collagen 
slab in the delivery process. Then the microneedles penetrated the parafilm and went into the 
collagen slab as shown in Figure 3.14. The drug could be delivered through microneedles and 




Figure 3.14 46 Scheme describing experimental setup to test microneedle device in an in vitro 
hydrogel skin model. Mironeedles penetrate parafilm and collagen hydrogel to subsequently 
deliver drugs with controlled pressure and electric field. 
In the test of glucose delivery, glucose solution was delivered into the collagen slab under 
different pressure and duration. Then the collagen slabs were digested in 1mg/mL collagenase 
(Sigma Aldrich, Singapore) at room temperature. It took around 1h for all the collagen slabs to be 
fully digested. The solution was collected to measure the glucose concentration with Glucose 
Detection kit (Abcam, Singapore). By comparing the readings from the kit with the measured 
concentration standard curve[70], the concentration of the glucose in hydrogel was measured. 
According to the glucose concentration, the absorption rate and solution delivery rate of the 
glucose in the hydrogel were calculated. 
Figure 3. 15 shows that the transport rate of glucose is proportional to the given pressure and 
the duration of the tests. When the pressure is lower than 1 kPa, no glucose could be detected. It 
indicates that the CNT nanofilters could be used as a pressure valve for the delivery of glucose. 
The delivery rate is around 70% for all the test data. It means around 30% of the drug would leak 
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to the surface. More importantly, after the pathways are created through the stratum corneum layer 
by microneedles, the drug which leaked to the skin surface eventually diffused into a deeper layer 
under the stratum corneum layer [71]. 
 
Figure 3.15 47 Glucose delivery quantity as a function of pressure. 
 
We conducted the same hydrogel absorption experiment for insulin. Insulin is a peptide hormone 
and central for regulating carbohydrate and fat metabolism in the body. Due to the poor absorption 
or enzymatic degradation of insulin in the gastrointestinal tract and liver, the transdermal delivery 
has been so far the preferred method of insulin administration. The molecular radius of insulin is 
1.34nm[72] which is smaller than the inner diameter of the CNTs in the device. It could pass through 
the CNTs just by applying pressure. Since the insulin molecules are positively charged in the 
solution, the transport rate could be tuned by applying electric field.  
The insulin solution of 1mg/ml concentration was preloaded in the drug reservoir. Air pressure 
levels in the range from 5kPa to 20kPa were applied for 30mins. The resultant solution samples 
were analyzed by FTIR as shown in Figure 3. 16 (a). The peak value indicates the concentration 
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of insulin in the sampled solutions. From the test results, the concentration of insulin is 
proportional to the pressure level which means the transport rate of insulin through CNTs is linear 
to the pressure level.  
Then the test was repeated by applying bias ranges from -10V to +10V and air pressure ranges 
from 5kPa to 20kPa. The peak value of IR spectra at 4.7μm wavelength was recorded in Figure 3. 
16 (b). The positive bias could facilitate the transport of insulin and negative bias could decrease 
the transport rate. For the line of -7.5V and -10V, when the pressure was lower than 10kPa, the IR 
spectra at 4.7μm wavelength was lower than the noise level thus no insulin was detected. This 
result indicates that the CNT nanofilters could be used as both pressure valve and electric switch 
for the delivery of insulin. And a sufficient reverse bias could balance the air pressure, realizing a 





Figure 3.16 48 Insulin delivery test result: (a) IR spectra of insulin by applying different pressure; 
(b) The peak value of IR spectra by applying different pressure and bias of electric field. 
Hemagglutinin is a type of antibody that agglutinates red blood cells. It is a cylindrical molecule 
whose longitudinal dimension and diameter are is 13.5 and 6.5nm, respectively [73]. Because the 
length of the molecule, 13.5nm, is larger than the inner diameter of the CNT nanotubes, 10nm, the 
Hemagglutinin cannot pass through the CNT just by applying pressure. 
According to our previous study [74], Hemagglutinin can pass through the CNTs when both 
electric field and pressure are applied together. This is because the cylindrical molecule can be 
aligned by the DEP force. 
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In the test, we applied 5V bias for 1 hour. The pressure changes from 5kPa to 20kPa. The 
sample solution was analyzed with FTIR. The IR spectra were shown in Fig. 3. 17. Due to that we 
used a water based s0olution as background for FTIR analysis, some negative peaks occurred in 
the spectra meaning the absorption was lower than water at that wavelength. The peak value was 
not in proportion to the pressure which indicates that the transport rate of large molecules is not 
proportional to the pressure. No heamagglutinin was detected when no electric field was applied. 
Therefore, the CNT nanofilters could act as an electric switch for the delivery of heamagglutinin. 
 
 
Figure 3.1749 IR spectra of Hemagglutinin by applying different pressure. 
The transport conditions of glucose and Hemagglutinin through CNT nanofilters are different. 
So if glucose and Hemagglutinin are mixed together, a selective transport could be realized by 
controlling the pressure and electric field applied. Then we mixed the glucose and Hemagglutinin 
together and conducted the test again. In one test, only 20kPa pressure was applied. In another test 
5V bias and 20kPa pressure were applied. The duration of both tests was one hour. The IR spectra 
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were shown in Figure 3.18. The green line is the reference of Hemagglutinin and the brown line 
is the reference of glucose. For Hemagglutinin, there is a negative peak at 3.5μm. For glucose, 
there is a positive peak at 4.3μm. When only pressure was applied, only glucose was detected. The 
blue line shows the similar curve as the brown line without the negative peak at 3.5μm. When both 
pressure and electric field were applied, both Hemagglutinin and glucose could be detected. The 
red line indicates both the negative peak at 3.5μm. and positive peak at 4.3μm. This result confirms 
that by controlling the conditions, Hemagglutinin could be selectively delivered while glucose 
could always be delivered. 
 
Figure 3.18 50 IR spectra of mixture solution of difference conditions. 
3.3 Conclusion 
A microneedle array integrated with CNT nanofilters for realization of controlled and selective 
drug delivery has been reported. The SU-8 tips made by the double drawing lithography process 
are sharp and stiff enough to penetrate skin. Nanobeads of 80 nm diameter were blocked in the 
test. It indicates there were no nano-scale cracks in the device and the CNT nanofilters could block 
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all substance larger than its inner diameter. The device could be used for controlled selective 
transdermal drug delivery. The transport rate of glucose and insulin of low molecular weight is 
proportional to the pressure given. But the transport rate of Hemagglutinin, i.e., a large molecule, 
is not in proportion to the pressure. The transport rate of charged molecule such as insulin could 
be tuned by an electric field. For the molecule which could be aligned by DEP force to pass through 
the CNT inner channel, CNT nanofilters could be used as an electrical switch. When the molecule 
is much smaller than the inner diameter of the CNTs, CNT nanofilters could be used as a pressure 
valve. The function of drug administration could be implemented by having the CNT nanofilters 
in microneedle array. It could expand the application of microneedles for a long term automatically 
disease monitoring and drug delivery system. 
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Chapter 4 Bendable microneedle  
Currently the safety issue caused by needle breakage after skin penetration step is the main 
concern for clinically relevant applications. High aspect ratio and sharp tips made of rigid materials 
are necessary for conventional microneedles to provide a successful and reliable skin penetration 
[76-77]. Normally, microneedles made of materials of high Young's modulus such as nickel [78-79], 
stainless steel [80-81] and silicon [82-83], can avoid this needle breakage. However, these materials 
lack of biocompatibility, which is a key requirement for medical devices. On the other hand, 
microneedles made of bio-compatible polymers or natural fibers suffer from low mechanical 
strength. The consequent needle breakage can be induced either by very high buckling force 
attributed to the deformable skin surface during the skin penetration or by the lateral movement 
between the microneedle patch and the skin surface during the drug administration.  
Thus, a novel bendable microneedle is proposed in this chapter to avoid the needle 
breakage during the drug administration. This bendable microneedle array with a soft base and a 
rigid sharp tip can tolerate the deformation associated with skin stretching without breakage when 
the skin patch is applied on the joint such as elbow and knuckle for osteoporosis treatment. In other 
cases, such as diabetes, for which microneedle patches are normally applied on the arm or abdomen, 
a lateral movement between the microneedle patch and skin surface may occur due to either the 
occasional touch or friction. In such case, the bendable microneedle will be dragged out of the skin 
instead of leaving a broken needle in the skin when lateral movement occurs. The sharp tips 
assembled onto the soft bases can be either non bio-dissolvable, i.e., made of SU-8 [84], or bio-
dissolvable, i.e. made of maltose [85]. For the configuration with SU-8 sharp tips, the outlets of the 
microneedles, connecting with the drug reservoirs, are always exposed to air. Both water-soluble 
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and lipophilic drugs can be immediately delivered just after skin penetration. For the configuration 
with maltose sharp tips, the outlets can be fully encapsulated by maltose to inhibit the solvent 
evaporation of lipophilic drug formulation [86]. The drug can be delivered when the maltose tips 
are melted after skin penetration. However, the microneedle with maltose tip is not suitable for 
application of water-soluble drug formulation [87]. The evaporation of water in solvent will cause 
maltose tip melting. Therefore, the water-soluable drug formulation can only be stored in patches 
with SU-8 sharp tips. 
4.1 Configuration and Demonstration of the bendable microneedle 
In order to solve the needle breakage issue after skin penetration, a unique bendable 
microneedle design is proposed here. The bendable microneedle consists of two parts: a soft four-
beam-pillar base made of PDMS and a stiff SU-8 sharp tip. The material of the sharp tips can be 
either SU-8 (Figure 4.1(a)) or maltose (Figure 4.1(b)). These sharp tips were assembled onto the 
four-beam-pillar structured array, which has four vertical gaps along the sidewalls (Figure 4.1(a2) 
and Figure 4.1(b2)). These four vertical gaps serve two functions: firstly, because the sharp tips 
made of SU-8 are not bio-dissolvable, the drug could be delivered out through these gaps; secondly, 
during the drawing lithography process, the sharp tips could form an anchor shape in these gaps to 
enhance the adhesion between sharp tips and four-beam-pillar base. Due to the flexibility of the 
PDMS pillars, the needle will bend when the lateral force applied onto the microneedle exceeds 
the threshold. These anchors of the rigid sharp tips in the gaps could fix the sharp tips onto the 
PDMS pillar and protect them from detaching the PDMS pillars when the whole microneedle is 
bent. Figure 4.1(a3) and Figure 4.1(b3) show the demonstrations of the bendable needle when a 
glass slide pushes the microneedle array from a lateral direction. These needles will bend when 
the lateral force is applied. They will recover to the initial state as long as the force is removed. 
After skin penetration, the relative movement between the microneedle patch and skin is inevitable 
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during the manual operation, which is one the major reasons for needle breakage. The soft PDMS 
pillars at the bottom of the microneedles will bend to absorb the mechanical strain caused by lateral 
movement and further prevent the breaking when this relative movement occurs. Figure 4.1(a4) 
shows a demonstration when the relative movement between skin and microneedle occurs after 
skin penetration. The dash line indicates the contour profile of needle position inside skin; from 
(a4-i) to (a4-iii), the needle penetrated the skin, the whole sharp tip was into the skin; from (a4-
iv) to (a4-v), a lateral movement occurred, the needle had a displacement from its original position. 
The PDMS pillars beneath the SU-8 tip bended and the SU-8 tip still remained within the skin(a4-
vi);  the needle was taken out of the skin and recovered to its original shape without breakage. This 
demonstration confirms that when the relative movement occurs, the needles will bend to match 
the new position of the skin. If the relative movement is too large, then the needles will be dragged 






Figure 4.1 51 Demonstration of the bendable microneedle array. (a1) Optical image of the 
microneedle array with SU-8 sharp tips; (a2) Detailed optical image of an individual bendable 
microneedle with SU-8 sharp tip; (a3) Demonstration of the bendable microneedle array with SU-
8 sharp tips when an lateral force is applied; (i): A glass slide began pushing the needle array from 
a lateral direction, part of the needle array bent; (ii): All the needle array was pushed by the glass 
slide and bended; (iii): The glass slide was removed, all the needles recovered to their original 
shape without breakage; (a4) Demonstration of the bendable microneedle when relative movement 
between skin and microneedle occurs after skin penetration. The dash line is used to indicate the 
contour profile of needle position inside skin;(i) A bendable needle is out of skin before the 
penetration; (ii) The microneedle pressed to penetrated the skin; (iii) The whole needle is into the 
skin; (iv) Al lateral movement occurs, the skin moves rightwards. The need is bent to adapt the 
lateral movement; (v) The distance of the lateral movement exceeds the threshold of the bendable 
needle, then the microneedle is out of the penetration hole; (vi) Lower the skin sample and make 
the bendable microneedle separate from skin surface. The needle recovers to its initial shape; (b1) 
Optical image of the microneedle array with Maltose sharp tips; (b2) Detailed optical image of an 
individual bendable microneedle with maltose sharp tip; (b3) Demonstration of the bendable 
microneedle array with maltose sharp tips when an lateral force is applied. The process is similar 




4.2 Characterization and optimization of the bendable microneedles 
Due to the elasticity of PDMS, the bottom part of the microneedles, which is represented 
by the PDMS pillars, will bend when the force applied onto the microneedles exceeds the buckling 
force. To realize a successful skin penetration, the stiffness of the PDMS pillars are expected to be 
as high as possible. Thus, we conducted a study of the stiffness of the PDMS by tuning the mix 
ratio of elastomer and curing agent. The PDMS with higher concentration of curing agent can have 
a higher stiffness. Here we tested the samples with mix a ratio of 1:4, 1:6, 1:8 and 1:10 for 
microneedles with both SU-8 and maltose sharp tips. Individual microneedles with PDMS base 
and SU-8 sharp tips were subjected to load in order to study their mechanical stability. The 
variation of measured bending force versus displacement was recorded. Figure 4.2(a) shows the 
measured curve of one sample. There are three parts: non-contact region, contact region and bend 
point, as indicated in this curve. The sharp drop of the force after the bend point confirms that the 
needles will not bend when the applied force is below the threshold. The forces of bend points of 
all the samples with different mix ratio of PDMS are shown in Figure 4.2(b). For each mix ratio, 
10 needles were tested. As shown in Figure 4.2(b), for the mix ratio of 1:4, the bending force is 
about 0.8N for SU-8 sharp tips and 1.14N for maltose sharp tips. The bending force decreases with 
the decrease of the mix ratio. The buckling force of needle with maltose sharp tip is higher than 
that of the needle with SU-8 sharp tip because of the different shapes of the sharp tips. As shown 
in Figure 4.1(a2) and (b2), the SU-8 sharp tip is slimmer than the maltose needle. This is because 
the viscosity of SU-8 is lower than that of maltose. During the drawing lithography process, the 
SU-8 sharp tip tends to have a slim central part while maltose sharp tip tends to have a thicker and 
stronger central part. Thus the force to make the needle with SU-8 sharp tip bent is lower than that 
of the needle with maltose sharp tip. Based on previous research[144], the force required for skin 
penetration ranges from 0.1N to 3N for an individual microneedle. The bending force of the 
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microneedle cannot be higher than the maximum force required for skin penetration, which is 3N. 
Thus our bendable microneedle may not able to realize a stable skin penetration.  Here we 
conducted the skin penetration tests with samples of different PDMS ratio to check the 
performance of skin penetration. A 3x3 microneedle array was applied onto skin and the number 
of penetrated holes created by needles was recorded and the results are shown in Figure 4.2(c) and 
recorded in Table 1. For the samples with a mix ratio of 1:4, there are 8 Figure 4.2(i-1) and 6 
Figure 4.2(i-2) penetrated holes on skin for needles with SU-8 sharp tips and maltose sharp tips 
respectively. For the samples with mix ratio of 1:6, there are 4 Figure 4.2(ii-1) and 3 Figure 4.2(ii-
2) penetrated holes on skin for needles with SU-8 sharp tips and maltose sharp tips respectively. 
For the samples with a mix ratio of 1:8, there is no penetrated hole that can be found on skin for 
both needle configurations, as shown in Figure 4.2(iii-1) and Figure 4.2(iii-2). Thus, we could 
conclude that, in order to ensure a good skin penetration, the mix ratio of 1:4 is desirable for the 
device fabrication. The success penetration rate of the needle with maltose sharp tip is lower than 
that of needle with SU-8 sharp tip when the test results of buckling force show an inverse trend. 
Although the maltose needle can stand a higher buckling force, it also requires higher force to 
penetrate the skin. This is because the thicker needle body of maltose sharp tip will affect a wider 
surface area during skin penetration, thus resulting in a higher possibility to get bent during skin 
penetration. Figure 4.2(d) shows the histology image of skin penetration by needles with SU-8 
sharp tip and maltose sharp tip. The micro-channel created by the maltose sharp (Figure 4.2(d-i-
2))  tip is broader than that of the SU-8 sharp tip(Figure 4.2(d-i-1)), which confirms that the 
maltose sharp tip requires more force to penetrate skin. Another parameter that may affect the 
buckling force of the bendable microneedles is the angular of the PDMS pillars beneath the rigid 
sharp tips. When the angular of the pillars decreases from 60°to 30° and the angular of gaps 
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between pillars increases from 30° to 60°, the anchor of the rigid sharp tip will take a higher ratio, 
making the needle more rigid and enhancing the buckling force. However, for the assembly of SU-
8 sharp tips by double drawing lithography, the baking time to melt the SU-8 tip assembled by the 
first step drawing cannot be well controlled to realize a partially filled gap for the samples with 
pillar angular lower than 55°. Because of the large gap angular, once melted, the SU-8 always fills 
the whole gap, leaving no outlet for the drug to be delivered. Therefore, for the needles with SU-
8 sharp tips, we only use the pillars of 60°pillar angular. The drawing process to assemble maltose 
sharp tip is not limited by the pillar angular, thus the buckling force of needle with maltose needle 
by changing the pillar angular is evaluated and reported in Figure 4.2(f). For each pillar angular, 
9 needles were tested. When the pillar angular decreases from 60° to 30° (Figure 4.2(e)), the 
buckling force of the individual needle increases from 0.43N to 0.92N because the whole 
microneedle becomes more rigid. However, the contact area between maltose and PDMS pillars 
also decreases with the decrease of the pillar angular. Thus the maltose sharp tip cannot be well 
fixed within the PDMS pillars and tends to break or detach from the PDMS pillars when the 
vertical force is applied to make the microneedle bent. For the case of 30° pillar angular, 8 of 9 
needles showed sharp tip breakage. The possibility of the needle breakage decreases with the 
increase of pillar angular. For the needles of pillar angular more than 50°, no needle breakage was 
observed in the buckling force tests. As a conclusion, to avoid needle breakage and have buckling 
force as high as possible, pillar angular of 50° is the optimum value for microneedles with maltose 
sharp tips. 
 
Table 1. Details of success rate of skin penetration for needles with SU-8 and maltose sharp tips 
when the mix ratio of PDMS changes from 1:4 to 1:10.  
       Mix ratio 
Needle type 
1:4 1:6 1:8 1:10 
SU-8 sharp 
tips 





6/9 2/9 0/9 0/9 
 
 
Figure 4.252 Optimization of PDMS stiffness and pillar angular of bendable microneedles for 
higher buckling force and success rate of skin penetration. (a) A representative example of the 
buckling force test result for bendable microneedle; (b) A representative example of the buckling 
force test result for bendable microneedle; (c) (c) Skin penetration results of microneedle with 
PDMS mix ratio of 4:1, 6:1 and 8:1 for needles with SU-8((i-1), (ii-1) and (iii-1)) and maltose((i-
2), (ii-2) and (iii-2)) sharp tips: (i-1) and (i-2): The mix ratio is 4:1 and the number of penetrated 
holes are 8 and 6 respectively ; (ii-1) and (ii-2): The mix ratio is 6:1 and the number of penetrated 
holes are4 and 3 respectively; (iii-1) and (iii-2): The mix ratio is 8:1 and there is no penetration 
holes on the skin; (d) Histology image of skin penetration by needles with SU-8 sharp tip(i-1) and 
maltose sharp tip(i-2). The scale bar is 200μm; (e) Optical image of the PDMS pillar of angular 
changing from 60° to 30°; (f) Buckling force test and possibility of needle breakage of needle with 





A unique bendable microneedles were proposed to overcome the safety issue associated 
with the microneedle breakage during the application. The PDMS mix ratio and pillar spacing are 
optimized for a maximum buckling force to enhance the skin penetration success rate. To adapt 
the applications for water-soluble and lipophilic drug formulations, two kinds of microneedle 
configurations are developed. Microneedles with SU-8 sharp tips are more suitable for the storage 
of water-based drugs while microneedles with maltose sharp tips are more suitable for the storage 
of lipid-based drugs. Such bendable microneedle can be integrated onto other flexible skin patch 
for transdermal drug delivery. 
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Chapter 5 Self-powered Wearable Adhesive Skin Patch 
with Bendable Microneedle Array for Transdermal 
Drug Delivery 
Wearable flexible electronic medical devices have received major attention recently owing 
to their considerable practicability for several applications [88-97], including health monitoring and 
drug delivery for disease treatment [98-100]. The bendable microneedle introduced in the last chapter 
is promising to be integrated with flexible electronic device to realize a wearable drug delivery 
function. 
Moreover, one key feature for wearable medical device is the fixation method. Acrylic 
medical bandage is widely used for medical patches. However, aging skin is more sensitive and 
vulnerable to a prolonged exposure to Acrylic medical bandage which is skin irritating and non-
bio-compatible. Dry adhesive, which is inspired by the hierarchical structure on Gecko foot hair 
[101-102], possesses several advantages compared with conventional acrylic medical bandages: First, 
it shows repeatable and restorable adhesion with surface cleaning after each usage. Second, the 
physical structure to generate adhesive force is less affected by surface contamination, oxidation 
and other environmental stimuli. Third, the space between the pillars for ventilation of air should 
provide better bio-compatibility. Hence, we also adopt the dry adhesive for the fixation of the 
whole device on the skin.  
To construct a complete drug delivery system for home healthcare monitoring, it is 
important to have feedback control function of the delivered drug. It can alert patients and provide 
the guidance when the dose of the drug to be delivered should be accurately controlled [103-106]. 
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Currently, several wearable sensors for health monitoring have been explored, including devices 
that measure hydration [107], strain [108], glycaemia [109-111], metabolic acid [112] and cardiorespiratory 
signals [113]. For a further integration of diversified sensors mentioned above and construct a 
standalone wearable drug delivery skin patch with capability of health monitoring, signal process 
and interfacing with external cloud computing apparatus, a built-in energy source is inevitable to 
power components such as integrated circuits(ICs), microprocessor, liquid-crystal display(LCD) 
reading panel. Triboelectric energy harvester (TEH) typically using patterned PDMS is compatible 
with the fabrication process of flexible skin patch with microneedles. Thus, TEH is the most 
promising technique to fulfil the above-mentioned requirements.  
In this chapter, the bendable microneedles were integrated on a wearable skin patch. The 
micro-patterns of the dry adhesives can provide the adhesive force.  Meanwhile, the same 
microstructure of the dry adhesive are used for triboelectric patch to harvest energy from the 
contact with human skin, which has not been reported yet. Considering the locations for patch 
attached can be on flat skin surface like arm and abdomen or on joints like elbow and knuckle in 
different applications, we studied and developed two kinds of configurations to adapt these two 
situations for energy harvesting. 
5.1 Configuration and fabrication process of the microneedle skin patch 
We propose a stretchable adhesive flexible microneedle skin patch attached onto flat skin 
surface or joint parts, i.e., s elbow and knuckle, as shown in Figure 5.1 (a). The whole skin patch 
consists of four functional components: bendable microneedle patch; dry adhesive patch; 
triboelectric energy harvester patch and drug delivery system with pump and drug reservoirs 
connected to the bendable microneedle skin patch. The detailed structure is depicted in Figure 5.1 
(b). The microneedle and triboelectric patches are connected with three dry adhesive patches to 
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make the whole wearable device able to be fixed onto the curved skin surface. The microfluidic 
control system with pump and drug reservoirs [113] can be assembled at the backside of the 
microneedle patch to control the drug delivery after the skin penetration. The detailed working 
principle of the pump system will be introduced in Chapter 6. 
The structure of an individual bendable microneedle is shown in Figure 5.1 (c) where it 
consists of a bendable four-beam-pillar base and a rigid sharp tip. The bendable pillar base is made 
of PDMS with optimized stiffness to ensure a high success rate of skin penetration, while certain 
volume deformation is allowed. A rigid sharp tip for skin penetration can be assembled onto the 
four-beam-pillar base structure by using double drawing lithography process. The gaps between 
the pillars can be partially filled with the same materials to form microneedles during the drawing 
lithography step. It provides anchoring between the sharp tip and soft base in order to fix the sharp 
tip onto the soft base and protect it from breakage when the whole microneedle is bent. Another 
functional component is the TEH patch for energy harvester. The triboelectric contact surface with 
PDMS micro-patterned structure can enhance the performance. Here we used the micro-pillar 
array with and without mushroom top, which is obtained from the same fabrication process of the 
dry adhesive patch, as the surface micro structure for TEH patch. Meanwhile, we also tested the 
sample with pyramid micro structure, which is normally used for TEH [114-117], as a comparison.  
Two methods were developed to generate power from the TEH patch by applying the skin 
patch on different locations of the human body. When the patch is attached to the elbow of a 
straight forearm, the spacing between two dry adhesive patches is slightly shorter than the length 
of the TEH patch. Thus the TEH patch is bent and has no contact with skin surface at this initial 
state. Then when the joint is bent, the TEH patch is stretched and in contact with the skin. 
Thereafter, when the joint is straight again, the spacing between two dry adhesive patches is 
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compressed to make the TEH bent and separate from skin. Power can be harvested by repeating 
this cycle as illustrated in Figure 5.1 (g).  
For the case in which the patch is applied onto a flat skin surface like arm and abdomen, 
power can be generated by pressing and releasing the TEH patch to induce contact and separation 
between TEH patch and skin surface as illustrated in Figure 5.1 (f). However, due to the sticky 
surface of PDMS, once the triboelectric contact surface is pressed onto skin, it cannot 
automatically separate from skin when the pressing is released. To solve this problem, a dry 
adhesive patch is assembled at the backside of the TEH patch as shown in Figure 5.1 (d). When 
the finger lifts up, the dry adhesive can provide a pulling force to make the TEH detach from the 
skin surface. Because the adhesive force provided by the dry adhesive is limited, the dry adhesive 
will detach from finger when lifted up to a certain height. In order to have a maximized output 





Figure 5.1 53  (a) Concept of the flexible microneedle skin patch attached on arm, elbow and 
knuckle. The patch consists of four functional components integrated on a whole PDMS sheet: 
Microneedle patch; Dry adhesive patch, TEH patch and pump system. (b) Detailed structure and 
functional components of the flexible microneedle skin patch; (c) Detailed structure of an 
individual bendable microneedle; (d) Detailed layer structure of the TEH patch; (e) Image of 
fabricated skin patch; (f) Attach the patch on flat skin surface like arm, power can be generated by 
pressing and lifting up the TEH patch (g) Attach the patch at the joint like elbow or finger, power 
can be generated by bending and unbending the elbow or finger. 
 
The dry adhesive film in the skin patch is used to fix the whole device onto skin surface 
and also provides the pulling force to separate the TEH patch from the skin which will be 





Figure 5.254 The fabrication process of the flexible microneedle skin patch. 
5.1.1. Fabrication process for bendable microneedle array 
(a), (b) and (c) show the fabrication process of the bendable microneedle patch. This 
microneedle comprises two PDMS layers and sharp tips.  
113 
 
The first PDMS layer is for the pillars supporting the sharp tips and the film holding the PDMS 
pillars as shown from (a1) to (a3). A SU-8 layer on silicon substrate was patterned to form the 
holes which are used as the mold for PDMS pillars as shown (i) and (vi). A SU-8 pillar was further 
patterned at the center of the holes as shown in (a2), (ii) and (vii). A PDMS layer was then spin 
coated onto the SU-8 layer to fill the SU-8 holes. But the thickness was not thick enough to cover 
the top of the SU-8 pillar as shown in (a3) and (iii). Thus, after the release of the PDMS layer off 
from the SU-8 layer, there will be a delivery hole located at the center of the four PDMS pillars as 
shown in (iv). These delivery holes form the connection between microneedles and other 
microfluidic channels.  
The second layer is for the micro-channels array connecting the delivery holes as shown 
from (b1) to (b3). A SU-8 layer of the negative pattern of the micro-channel array was patterned 
on silicon substrate as shown in (b1) then covered with a PDMS layer as shown in (b2). Then the 
PDMS was cured by baking and released from the SU-8 layer as shown in (b3). A center hole was 
drilled by punch at the center of the channel array. This hole is to connect the channel array and 
the pump system in the final assembly process.  
Then align the second PDMS layer with the first layer of PDMS which is still on the SU-8 
mold as show in (c1) then bond these two layers by oxygen plasma treatment as shown in (c2). 
Release these two layers together off from the SU-8 mold as shown in (c3). Then rigid sharp tips 
were assembled by double drawing lithography as shown in (c4), (v), (x). (xi) shows the delivery 
hole within the four-beam pillar structure. The material can be maltose or SU-8 by leveraging the 




5.1.2 Fabrication process for dry adhesive 
The dry adhesive is fabricated by leveraging the inking and printing technology. A PDMS 
layer with un-inked micro-pillar array was achieved by demolding the PDMS from SU-8 mold as 
shown from (d1) to (d3). A SU-8 mold of 20μm thickness with micro-pattern of hole array was 
patterned on silicon substrate as shown in (d1). Then a PDMS layer was spun onto the SU-8 mold 
to fill all the holes on SU-8 mold as shown in (d2). Then cure and demold the PDMS layer off 
from the SU-8 mold as shown in (d3) and (viii). The height of the pillar is 20μm, which is the same 
as the thickness of the SU-8 mold. 
The mushroom top which is necessary for dry adhesive to enhance the adhesive force is 
achieved by inking and printing process as shown from (e1) to (e5). A thin film of un-cured PDMS 
(5μm) was spun coat on a silicon chip as shown in (e1). Then the array of un-inked micropillars is 
inked in the un-cured PDMS film as shown in (e2). Subsequently, when lift the PDMS layer up 
from the un-cured PDMS film, small drops of un-cured PDMS is placed at the top of the array of 
un-inked micropillars as shown in (e3). Then the array was gently pressed against a silicon chip 
with treatment of detergent on the surface to peel sample easily as shown in (e4). Bake the sample 
to cure the PDMS droplet and release the dry adhesive off from the silicon chip as shown in (e5) 
and (ix).  
5.1.3 Fabrication process for TEH patch 
We leverage the pillar array which is achieved in (d3) as the surface micro-pattern required 
for TEH patch. A copper layer (200nm) was deposited by thermal evaporation at the backside of 
the PDMS layer as shown in (f1). Then a kapton layer was attached above the copper layer to fix 
the metal wire and protect the metal from scratching as shown in (f2). To study the different of 
performance by using different surface micro-patterns, we also use the dry adhesive in (e5) instead 
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of the pillar array in (d3) for the TEH patch. As a comparison with normal triboelectric patch, the 
pyramid surface micro-pattern is also used for TEH patch.  
5.1.4 Fabrication process of the complete patch 
All the functional patches are assembled onto a long PDMS sheet (200μm thickness) as 
shown in (g). For bendable microneedle patch, dry adhesive and pump system, they can be directly 
bonded onto the PDMS sheet by oxygen plasma treatment. Before the bonding of the bendable 
microneedle patch, a hole was drilled and aligned to the hole on the backside of the bendable 
microneedle patch to connect the bendable microneedle patch and pump system. The TEH is fixed 
by double side tape onto the PDMS sheet because the backside of the TEH patch is Kapton and 
cannot be directly bonded by oxygen plasma. 
5.2 Characterization of the dry adhesive 
To ensure the patch can be steadily fixed onto the skin, the normal adhesive force of the 
dry adhesive patch with two sets of pillar (diameter of 11μm and 13μm) and different ratio of pillar 
spacing vs pillar diameter (range from 20/11 to 3 ) was characterized. The adhesion strength was 
measured up to 10 repeating cycles for each sample by Instron Microtester 5848 (Instron, USA). 
The sample was attached onto the glass or skin and the normal force was applied by the Microtester 
from the backside to peel the dry adhesive off. The maximum force was recorded as the adhesive 
force. Figure 5.3 (a) and (b) show the adhesive force on glass and skin of each cycle. The dry 
adhesive was cleaned with acetone after each cycle to prevent the contamination and recover the 
adhesive force. The sample with 20μm pillar spacing can achieve higher adhesive force than the 
sample with 24μm pillar spacing when the pillar diameter is 11μm. For the test on the glass, the 
adhesive force does not have an obvious decline as shown in Figure 5.3 (a). However, for the test 
on the skin, there is a decline of the adhesive force when repeating the test cycles. This is because 
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the deformable skin will cause more damage on the mushroom top when the dry adhesive was 
pressed onto skin surface. Thus repeating the test cycles will accumulate the damage of mushroom 
and further reduce the adhesive force.  
The characterization of the adhesive force on the glass and skin by changing the pillar 
spacing for pillars of 11μm and 13μm diameter is shown in Figure 5.3 (c) and (d). The test results 
agree with the data in (a) and (b). The adhesive force decreases when the spacing increases. And 
the adhesive force of the patch with 13μm diameter is a bit lower than that with 11μm due to the 
lower pillar aspect ratio when the pillar diameter is higher. Base on the characterization of the dry 
adhesive force, we can conclude that the sample with 11μm pillar diameter and 20μm pillar spacing 
can achieve the highest adhesive force. Therefore, this parameter is adopted for the dry adhesive 




Figure 5.355 Characterization of the adhesive force of dry adhesive patches by changing the pillar 
diameter and pillar spacing. Adhesive force test by repeating 10 cycles on glass (a) and on skin(b). 
After each test cycle, the dry adhesive patch was cleaned by acetone. The diameter of the pillar is 
11μm; Average adhesive force of the dry adhesive patches on glass(c) and skin(d) for samples 
with pillar diameter of 11μm and 13μm. 
5.3 Characterization of the TEH patch 
5.3.1 Comparison of the TEH patches with different surface micro-patterns 
A dielectric PDMS layer with micro-patterns was used to enhance the effective surface 
area and output voltage. Here we studied the performance by using micro-pillar with and without 
mushroom top and pyramid as the micro-patterns. At the backside of the dielectric PDMS layer, a 
Cu layer of 200nm thickness was deposited by thermal evaporation. Then a Kapton layer was 
attached above the Cu layer to protect the metal from scratching and friction. As mentioned before, 
to adapt the different locations for our patch to be applied, we developed two methods to generate 
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power. For the first case when the patch is applied on flat skin as shown in Figure 5.4 (a), the 
distance between two dry adhesive patches is a bit shorter than the original length of the TEH 
patch, making the TEH patch bent upward and having no contact with skin surface (Figure 5.4 (a-
1-i)). Then the TEH patch is pressed by finger and contact with the skin surface, as shown in 
Figure 4(a-1-ii), then is separated from skin again by lifting up the finger as shown in Figure 5.4 
(a-1-iii). Due to the sticky surface of PDMS, once the TEH is attached onto the skin, it cannot 
separate from skin without a pulling force. Thus, a dry adhesive patch is assembled at the backside 
of the TEH patch, providing the pulling force by having the adhesive force between the finger and 
dry adhesive patch. The detailed charge transport process is shown in Figure 5.4 (a-2). When the 
TEH patch was pressed onto the skin surface (Figure 5.4 (a-2-i)), there is charge transport between 
them. According to the triboelectric theory, electrons are transferred from the PDMS to the skin 
during the electrification process, since PDMS is more triboelectrically negative than skin as 
shown in Figure 5.4 (a-2-ii). The change of the negative charges on the surface of the PDMS 
induces positive charges on the Cu electrode, driving free electrons to flow from the Cu layer to 
the ground. An output voltage or signal is generated. Once the finger is lifted up, making the PDMS 
and skin separated (Figure 5.4 (a-2-iii)), the recovery of the surface negative charge on PDMS 
surface will induce a backflow of electrons from ground to Cu electrode. An opposite signal will 
be generated.  
According to the V–Q–x relationship for contact-mode TEHs [119], the output voltage is 
determined by the following equation: 
  𝑽𝑽 = 𝑬𝑬𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅 × 𝒅𝒅 + 𝑬𝑬𝒂𝒂𝒅𝒅𝒅𝒅 × 𝒙𝒙  ……………………..(1)                                                                                                                         
where Edielectric is the electric field though the dielectric layer, which is PDMS layer here, 
generated by the tribo-charges on the opposite sides of the TEH; d is the thickness of the dielectric 
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layer; Eair is the electric field though the spacing between the top surface of TEH and contact 
surface, this electric field is generated by the tribo-charges on the TEH surface and contact surface; 
x is the spacing between the TEH surface and contact surface. The output voltage should increase 
with the increase of the spacing between the TEH surface and contact surface in the ideal fully 
contact-mode TEHs. Thus to achieve the maximum output power, the TEH should be lifted up as 
high as possible. The maximum height to be lifted up is determined by the spacing between the 
two adhesives. When this spacing decreases, the TEH can bend upward more and have a large 
distance away from the skin surface. However, a shorter spacing between the two dry adhesive 
patches also decreases the effective contact area between the TEH patch and skin. It will further 
lower the quantity of the tribo-charges to be generated. The spacing between the two dry adhesive 
patches is optimized in Figure 5.5 to achieve a maximum lift-up height. The adhesive force should 
provide a certain adhesive force to lift up the TEH to the maximum height. Otherwise, before the 
TEH is lifted up to the maximum height, the finger will detach from the dry adhesive because of 
the insufficient pull force. Based on the adhesive force characterization in Figure 5.4, output 
voltage of dry adhesive patches with different adhesive forces are tested in Figure 5.5. The dry 
adhesive with highest output voltage was selected to be assembled at the backside of the TEH for 
output power characterization in Figure 5.4 (b) and Figure 5.4 (c).  
In order to calculate the power generated by the TEH, a load resistor was connected 
between TEH patch and ground. The finger pressing of 2Hz frequency was applied to generate the 
power. The voltage was then measured across the load resistor to obtain the power generated by 
the TEH. As the load resistance was increased, the power output increased, peaked at a point, and 
then started dropping thereafter. The voltage and power characteristics of TEH with different 
surface micro-patterns and load resistance are shown in Fig 5(b) and 5(c). The maximum power 
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output for TEH patch with pillar with and without mushroom top assembly and pyramid are 11.79 
μW, 13.3 μW and 15.21 μW, respectively; when the load resistance values are approximately 23.08 
MΩ, 37.5 MΩ and 44.44 MΩ, respectively, as shown in Figure 5.4 (c). This load resistance for 
peak output power represents the inner impedance of the TEH patch. The TEH with pyramid 
surface micro-patterns generates a higher voltage and output power, but also gives a higher inner 









≈        ……………………..(2)                                                                                                                         
where Ropt is the inner impedance; d0 is the thickness of the PDMS layer; xmax is the 
maximum height to be lifted up for TEH patch; S is the effective area size of TEH patch which 
can be altered by the surface micro-patterns; v is the speed of the TEH to be lifted up; ε0 is the 
dielectric constant of air. 
For the TEH patches whose surface micro-patterns are pillar with and without mushroom 
tops, the contact surface is stickier than the TEH patches with pyramid surface micro-pattern. Thus 
when the TEH patches were lifted up, TEH with pyramid surface micro-pattern has a faster 
detachment from skin, thus with a higher v, result in a narrower and higher output voltage pulse. 
However, when the height of the micro-pillar, which is 20μm, is much higher than the height of 
the pyramid, which is 1.37μm, the micro-pillar structure can provide a higher S, effective area size 
of TEH patch, than the pyramid structure and further lower the inner impedance.  
Another method to generate the power is to attach the device to the joint. In this case, when 
people bend and straight their joint, the skin will be stretched and compressed, making the TEH 
patch contact and detach the skin. Thus, the dry adhesive on the backside of TEH patch is not 
required. The test result of the output voltage and output power is shown in Figure 5.4 (d) and (e) 
showing the same trend as that of (b) and (c). The maximum power output for TEH patch with 
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pillar with and without mushroom top assembly and pyramid are 12.4 μW, 13.4 μW and 15.6 μW, 





Figure 5.456 (a) Working principle of the TEH patch when applied on flat skin surface; 
Characterization for the TEH output voltage(b) and power(c) when applied on flat skin; 
Characterization for the TEH output voltage(d) and power(e) when applied on finger knuckle. 
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5.3.2 Optimization for TEH patch configuration 
 
Figure 5.557 Open circuit voltage by changing the spacing between two adhesive for the TEH 
attached on arm; (b) Open circuit voltage by changing the pillar spacing of the dry adhesive patch 
at the backside of the TEH patch; (c) Open circuit voltage by changing the spacing between two 
adhesive for the TEH attached on finger knuckle; (d) Average width of the pulse for the signal in 
(a).  
The spacing between the two dry adhesive patches beside the TEH patch will affect the 
maximum height to be lifted up and further affect the maximum output voltage. The test results of 
the output voltage of the TEH patch by changing the spacing between two dry adhesive patches 
for the situation when the TEH was applied on arm is shown in (Figure 5.5 (a)). The length of the 
TEH patch is 2cm. Thus the spacing between two dry adhesive patches decreases from 2 cm to 
1cm with 0.2cm step. The output voltage peaks at 1.4cm because the increase of the height to be 
lifted up. Then it declines by reducing the spacing because the effective contact area reduces when 
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the spacing is too low. For the situation when the TEH patch was applied on finger knuckle, the 
rest results are shown in Figure 5.5 (c). The output voltage peaks at 1.6cm. Another fact will affect 
the lift- up height is the adhesive force of the dry adhesive patch assembled at the backside of the 
TEH patch. If the adhesive force is not sufficient, it will detach from finger before the TEH patch 
is lifted up to the maximum height. Based on the adhesive force characterization in Figure 5.4, we 
selected the sample of 11μm and pillar spacing ranges from 20μm to 32μm in the test. In this test, 
only micro-pillar without mushroom top is used. As shown in Figure 5.5 (b), the voltage decrease 
with the increase of the pillar spacing because of the reduction of the adhesive force. Only the dry 
adhesive patch with 20μm spacing can give the highest output voltage which indicates that the 
highest lift-up height. The width of the pulse for the signal measured in Figure 5.5 (a) is shown in 
Figure 5.5 (d). As mentioned in paper, because the TEH patch with pillar-based micro-pattern is 
stickier than that with pyramid micro-pattern, thus it takes longer time to detach from skin surface 
and generate a broader pulse. The average width of the pulse for pyramid, pillar with and without 
mushroom top assembly is 19ms, 22ms and 26ms, respectively.  
 5.4 Conclusion 
We developed a stretchable wearable flexible medical device for transdermal drug delivery. 
Unique bendable microneedles were proposed to overcome the safety issue associated with the 
microneedle breakage during the application. The PDMS mix ratio and pillar spacing are 
optimized for a maximum buckling force to enhance the skin penetration success rate. To adapt 
the applications for water-soluable and lipophilic drug formulations, two kinds of microneedle 
configurations are developed. Microneedles with SU-8 sharp tips are more suitable for the storage 
of water-based drugs while microneedles with maltose sharp tips are more suitable for the storage 
of lipid-based drugs. We leverage the dry adhesive as the fixation method to realize a conformal 
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attachment. The micro-pillar structure achieved in fabrication of dry adhesive is also investigated 
as a TEH patch which is a promising energy source for other active components. Two methods for 
power generation, based on different positions for skin patch to be attached, were developed and 
characterized. Thus the TEH patch can generate power no matter the patch is attached on flat skin 




Chapter 6 Towards self-powered Microneedle skin 
patch integrated with Triboelectric liquid volume 
sensor for lab-on-chip applications  
For the treatment of diseases such as type 2 diabetes and osteoporosis, multiple drug 
injections per day with dose control of each injection will be necessary. Thus, large delivery 
volume and a precise control mechanism are desirable features for wearable skin patch drug 
delivery system but not developed yet. It means within the skin patch, a liquid volume sensor with 
proper mechanism should be integrated with the fluidic system for drug loading and delivery. 
Moreover, a standalone wearable drug delivery skin patch with capability of health monitoring, 
signal processing and interfacing with external cloud computing apparatus, an built-in energy 
source is inevitable to power components such as integrated circuits (ICs), microprocessor, liquid-
crystal display (LCD) reading panel, drug delivery and control actuators, and diversified sensors, 
e.g., glucose sensor.  
In this chapter, we report a LoC drug delivery patch with manually-controlled drug delivery 
function and power source which is suitable for further integration with other active components 
for more applications. The key innovation of our design is that the liquid volume could be sensed 
by a triboelectric mechanism using the same materials for LoC. Thus the delivery volume can be 
well measured and controlled during the drug delivery process. The bendable microneedle array 
was assembled onto the patch to confirm the drug control function by insulin delivery tests on rats. 
By leveraging the similar triboelectric mechanism as the liquid sensor, we developed and 
optimized a stacked layer design triboelectric energy harvester(TEH) which is suitable to be 
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attached onto the patch as an energy source. Such energy source can be used to support the 
operation of other components. 
6.1 Structure and fabrication process 
6.1.1 Structure of the skin patch 
 
Figure 6.1 58 (a) Concept of the flexible microneedle skin patch attached on skin; (b) Detailed 
structure and functional components of the flexible microneedle skin patch with manual-controlled 
insulin delivery and delivery volume monitoring function. (i) TEH assembled on the top surface 
of the skin patch as power source for other functional active components to be integrated in the 
future; (ii) Delivery volume sensor using triboelectric mechanism to measure the drug volume to 
be delivered and control the insulin dose; (iii) Bendable microneedle array for skin penetration; 
(iv) Microfluidic control system including a pump chamber, two check-valves and drug reservoirs; 
insulin can be loaded and delivered by pressing the pump chamber. 
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We propose a flexible microneedle skin patch with manually-controlled drug delivery, dose 
volume monitoring, bendable microneedles and TEH as shown in Figure 6.1. The whole device 
consists of four functional components: microfluidics control system, bendable microneedle array 
for skin penetration, delivery volume sensor and TEH.  
The microfluidics control system has four parts: two check-valves in series, a pneumatic 
pump-chamber between these two check-valves, several drug reservoirs in series and microfluidic 
channels connecting all these components. By having this microfluidics control system, drugs can 
be manually loaded and delivered.  
The bendable microneedle array, connected with the microfluidic control system by a 
vertical channel, is assembled onto the top surface of the microneedle patch. After skin penetration, 
drugs stored in the drug reservoirs will be delivered into skin through this microneedle array when 
we use fingertip to press the pump chamber.  
The main component of the delivery volume sensor above the pump chamber leverages the 
triboelectric sensing mechanism which has yet been demonstrated as liquid volume sensor. 
Currently, triboelectric sensing mechanism has been investigated in terms of chemical sensor[120-
123], pressure sensor[124-126], motion sensor[127-133] and tactile sensor[134-136] because of its advantage 
of easy fabrication and self-powered feature. Here we assembled a triboelectric layer pair with the 




Figure 6.259 (A) Cross-sectional view of the lab-on-chip drug delivery patch; (B) Working 
principle of the TEH for the delivery volume sensor; (b1) to (b3) shows the a magnification of 
layer structure and charge polarity in (a1) to (a3).(C) Detailed image shows the parylene layer to 
encapsulate the TEH patch and coated on the bottom of the chamber. 
 
 A detailed cross-sectional view of the device without microneedle is shown in Figure 6.2. 
The microfluidics control system has four parts: two check-valves in series, a pneumatic pump-
chamber between these two check-valves, several drug reservoirs in series and microfluidic 
channels connecting all these components. By pressing the pump chamber, the liquid will be 
sucked into the channel from the inlet and delivered out from the outlet as shown in Figure 6.2 
(A). The detailed structure and working principle are shown in Figure 6.3. 
Figure 6.2 (B) shows a detailed structure of the TEH assembled for liquid volume sensor. 
A dielectric PDMS layer with pyramid shape micro-patterns was used to enhance the surface area 
and output voltage. Underneath the PDMS layer, a Kapton tape was attached as an intermediary 
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layer for metal deposition. To have a better adhesion between Cu and Kapton, a Cr layer was 
deposited before the deposition of Cu layer. In order to protect the metal layer, a parylene layer 
was coated by CVD onto the whole surface of the TEH, including the PDMS top surface. Then 
the TEH was assembled in a PDMS chamber with Al layer coated on the ceiling. 
In the original position, the surface of the TEH and ceiling are not in contact (Figure 6.2 
(a1) and (b1)). When the bottom layer of the pump chamber is pressed, the liquid or the air in the 
in the pump chamber will be compressed and the top layer of the pump chamber will also be 
deformed. This deformation will induce a contact between the top layer of the TEH and the ceiling 
of the PDMS chamber, resulting in charge transport between them (Figure 6.2 (a2) and (b2)). 
According to the triboelectric theory, electrons are transferred from the parylene to the Al during 
the electrification process, since parylene is triboelectrically negative and Al is triboelectrically 
positive. The change of the negative charges on the surface of the parylene can induce positive 
charges on the Cu electrode, driving free electrons to flow from the Cu layer to the ground. An 
output voltage or signal is generated. Once the pressing is released, the parylene and Al surfaces 
are separated (Figure 6.2 (a3) and (b3)). The recovery of the surface negative charge on parylene 
surface will induce a backflow of electrons from ground to Cu electrode. An opposite signal will 
be generated. The output voltage is generated by the contact between parylene and Al and it is 
determined by the contact area. And this contact area is also determined by the deformation of the 
pump-chamber, which is related with the delivery volume. Thus, based on the output signal, the 
delivery volume can be measured.  
To avoid the interference from the backside of the TEH, the bottom of the chamber is also 
coated with parylene as shown in Figure 6.2 (C). Thus, the backside of the TEH and the bottom 
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surface of the chamber are of the same material. The contact of these two interfaces will not 
generate any output voltage.  
To achieve the highest voltage, the surface materials of the triboelectric layer pair should 
be optimized. The gap between the top and bottom of the delivery volume sensor is critical to 
measurement accuracy of the liquid volume sensor. To ensure a good accuracy of this delivery 
volume sensor, this gap is also optimized. 




Figure 6.3 60 Structure and working principle of the pump chamber and check-valves. 
The design and working principle of the pump-chamber and check-valves are illustrated in 
Figure 6.3. The pump -chamber is located between two check-valves. The check-valve has three 
parts: a thin PDMS membrane layer with a hole, a top layer that contains a discontinuous channel, 
and a bottom layer that contains a short segment of a channel. The device was formed by bonding 
these three layers together. But the contact area between the protruding poster of the top layer and 
center membrane layer should not be treated with Oxygen plasma. When pressure applied, the 
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center membrane could detach from the top layer and deform. During the plasma treatment, the 
contact area will be covered by a piece of Al foil. These two check-valves ensure that the liquid or 
air can only enter the pump-chamber through one valve, and leave the pump-chamber through the 
other. Due to the elasticity of PDMS, when the bottom layer of the pump-chamber is pressed and 
deformed, the pressure in the pump-chamber will increase. For check-valve 1, this high pressure 
in the pump-chamber will make the chamber below the membrane expand. Thus the membrane 
will be pushed and attach tightly onto the protruding poster of the upper layer, sealing the channel. 
Then check-valve 1 is off. For check-valve 2, this high pressure in pump-chamber will push the 
membrane of the check-valve 2 and make it deform. Then check-valve 2 is on and the air or liquid 
in the pump chamber can pass through. When the bottom layer of the pump-chamber is released, 
the pump-chamber tends to recover its initial shape. Thus the pressure in pump-chamber is low. 
This low pressure in the pump-chamber will make the membrane of check-valve 1 have a 
downwards deformation. Then the check-valve 1 is on and the air or liquid outside the device can 
be sucked into the pump-chamber. Meanwhile the low pressure in pump-chamber will make the 
membrane of check-valve 2 have an upwards deformation and seal the channel. Then check-valve 
2 is off.  
In summary, one check-valve can be on only when another check-valve is off. Then a one 
directional flow can be formed by pressing the pump chamber. 




Figure 6.461 Fabrication process of the TEH 
Figure 6.4 shows the fabrication process of the TEH used for energy harvester and delivery 
volume sensor. The process of the TEH fabrication started from a Si wafer with pyramid shape 
holes as shown in (a). A PDMS layer was coated and cured onto the Si mold as shown in (b). The 
thickness of the PDMS layer was controlled by the spin rate of the spin coater. Then attach the 
Kapton tape at the backside of the PDMS layer as shown in (c). Two layers of metal were coated 
onto the Kapton tape by evaporation as shown in (d). The first layer of Cr is to enhance the 
adhesion between Cu and Kapton tape. Then PDMS layer with Kapton and metal layers was 
released from the Si mold and encapsulate it with parylene by CVD. This parylene layer can protect 
the metal from peeling off by scratch and contact with adhesive surfaces. In the test, the backside 
metal layers of the TEH were assembled onto PDMS surface which is adhesive. Thus if without 
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the parylene coating, the metal may detach from the TEH because of the contact with the adhesive 
PDMS surface. 
6.1.4 Fabrication process of the LoC drug delivery patch 
The fabrication process of the LoC drug delivery patch is as shown in the Figure 6.5. Two 
SU-8 molds were prepared first. The first SU-8 mold was for the upper layer of the check-valve, 
pump-chamber, drug reservoirs and fluidic channels ((a1) to (a2)). The SU-8 layer was coated and 
patterned on a glass wafer as shown in (a1). On this SU-8 mold, there were bases for pump-
chamber and drug reservoirs. Then SU-8 of liquid phase was dipped onto the SU-8 base and 
formed hemispheres as shown in (a2). Previous research reveals that the maximum skin absorption  
rate is around 33µL/day for each microneedle[143]. Considering the microneedle array has 8 
microneedles in our design, the total drug solution can be delivered  in one day is around 264 µL. 
Thus by controlling the volume of SU-8 dipped onto the substrate to form the drug reservoir, the 
total volume of the drug reservoir is 270 µL. The sample was baked to make the SU-8 hemispheres 
solidified. Then the sample was exposed with UV light and post baked to make the SU-8 crosslink. 
The second SU-8 mold is for the fluidic channels for microneedle array and chamber for TEH 
delivery volume sensor as shown in (b). To have a well control of the spacing of the chamber, a 
glass slide of certain thickness was attached onto the base of the chamber. Then the SU-8 molds 
of (a2) and (b) were face to face aligned and fixed with a spacer at the edge. The space between 
these two SU-8 molds was filled with PDMS as shown in (c1). These fixed SU-8 molds with 
PDMS in between were kept at room temperature for 24 hours without baking to avoid the air 
bubbles within the PDMS layer. Then sample was cured at 75ºC for 30 minutes. The sample was 
cooled down to room temperature and release these two SU-8 molds from the PDMS layer as 
shown in (c2). This PDMS layer has patterns on both sides and acts as the main body of the device. 
The top side has the channels for microneedle array and the bottom layer has the pattern for 
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microfluidic control system. To have the top PDMS layer for microneedle pillar array, a third SU-
8 mold was prepared ((d1) to (d3)). For this SU-8 mold, a SU-8 layer with hole array was patterned 
as shown in (d1). The holes were for the four-beam PDMS pillars. Then a pillar array was aligned 
to the hole pattern as the second SU-8 layer. The second layer is for the vertical channel connecting 
to the channel array on the top layer of (c2) with the microneedles which will be assembled later. 
Then PDMS was coated onto the SU-8 mold to fill the hole pattern and form a whole layer above 
the SU-8 mold as shown in (d3). The thickness of the PDMS layer (150 μm) was lower than the 
thickness of the height of the SU-8 pillar (350 μm). Thus the top of the SU-8 pillar was not covered 
by PDMS. This SU-8 mold can create a penetrated hole through the PDMS layer and form a 
vertical channel inside the microneedle. Make the sample of (d3) face down and bonded to the top 
surface of main body as shown in (c2). Then the SU-8 mold was released as shown in (c3). Now 
at the top surface of the main body of the device, a PDMS pillar array was aligned and connected 
to the channel array. Then for the bottom surface of the main body, two PDMS layer was needed 
to form the two check-valves. Thus two SU-8 molds were required. (e1) shows the SU-8 mold for 
the bottom chambers of check-valves. Then a thick PDMS layer was coated onto the SU-8 mold. 
Then cured PDMS was released as shown in (e2). (f1) shows the SU-8 mold for the holes on the 
center membrane layer of the check-valves. Then a thin layer of PDMS was coated onto the SU-8 
mold as shown in (f2). To create penetrated holes on this membrane layer, the thickness of the 
PDMS (40 μm) is lower than the height of the SU-8 pillar (350 μm). The PDMS layer of (e2) with 
(f2) were aligned as shown in (g1) and bond them together (g2). Then the bonded the PDMS layers 
were released from the SU-8 mold as shown in (g3). These bonded PDMS layers have the 
membrane with holes and chambers for the check-valve. These PDMS layers were aligned and 
bonded to the bottom surface of the main body as shown in (c4). Then the sharp tips were 
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assembled onto the PDMS pillar array as shown in (c5). This sharp tip assembly is realized by 
drawing lithography. Then the TEH was fixed at the bottom of the sensor chamber and a PDMS 







Figure 6.562 Fabrication process of the LoC drug delivery patch 
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6.2 Characterization and optimization 
6.2.1 Optimization and characterization of the surface materials of the triboelectric layer pair 
 
Figure 6.6 63 Optimization for PDMS thickness and material of contact surfaces; (b) 
Characterization of the output power; (c) Output voltage over time of the different triboelectric 
surface pairs when the thickness of the PDMS layer is 200μm. 
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To enhance the sensitivity of the delivery volume sensor, the output voltage of the TEH is 
expected to be as high as possible. Here we investigated the effect of surface pyramid micro-
pattern, material of contact surface and the thickness of the PDMS dielectric layer. Three groups 
of samples with different PDMS thickness are prepared as shown in the following table. 
Table 6.12 Details of groups of sample for optimization of PDMS thickness and contact surfaces 
Group No. Surface micro-pattern Contact surface Thickness of dielectric 
layer 
Group 1 Without pyramid micro-
pattern 













In the test, the TEH patches were fixed onto a force gauge and applied onto the PDMS or 
Al contact surface with the same force, which is 10 N. To make the open circuit output voltage of 
TEH reaches the maximum value, the surface of TEH is fully contacted with PDMS or Al surface.  
The experimental measurement data is shown in Figure 6.6 (a). According to the V–Q–x 
relationship for contact-mode TEHs, the output voltage is determined by the following equation: 
𝑉𝑉 = 𝐸𝐸𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 × 𝑑𝑑 + 𝐸𝐸𝑎𝑎𝑑𝑑𝑑𝑑 × 𝑥𝑥                        (1) 
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where Edielectric is the electric field though the dielectric layer generated by the tribo-charges on the 
opposite sides of the TEH; d is the thickness of the dielectric layer; Eair is the electric field though 
the spacing between the top surface of TEH and contact surface, this electric field is generated by 
the tribo-charges on the TEH surface and contact surface; x is the spacing between the TEH surface 
and contact surface. The output voltage should increase with the increase of the dielectric layer 
thickness in the ideal fully contact-mode TEHs. 
For group 1, there is no pyramid micro-pattern on the surface of TEH. The two contact 
surfaces are parylene and PDMS. The output voltage increases from 3.8 V to 9.5 V when the 
thickness of PDMS dielectric layer increases from 30 μm to 215 μm, which is consistent with the 
equation (1).  
For group 2, there are pyramid micro-patterns on the surface of TEH. The two contact 
surfaces are the same as group 1. Compared with the samples of group 1, the output voltages of 
the samples of group 2 have about 50% enhancement with the same PDMS thickness. The output 
voltage increases from 5.2 V to 14.6 V when the thickness of the PDMS dielectric layer increases 
from 30 μm to 215 μm. Thus the pyramid micro-pattern on the surface of TEH can enhance the 
output voltage by 50%.  
The samples of group 3 are the same as group 2. To further increase the output voltage, we 
changed another contact surface from PDMS to Al. Since Al is more triboelectrically positive than 
PDMS, these contact surfaces of parylene and Al could generate higher output voltage. For the 
samples of 30 μm, 80  μm and 150 μm, the output voltages are about 50% higher than their 
counterparts of group 2. For the sample of 215 μm thickness, the output voltage has 100% 
enhancement than the sample with the same thickness of group 2. This maybe induced by the too 
thick layer of PDMS. During the test, not only the surface pyramid micro-patterns get deformation, 
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but the PDMS layer itself also got serious deformation which induced more charge transport. Thus 
the enhancement of the output voltage of thicker PDMS dielectric layer is much higher than that 
of thinner PDMS dielectric layer. 
The output power for each group by changing the load resistance is shown in Figure 6.6 
(b). The change of the maximum output power for each group follows the same trend as that of 
open circuit output voltage as shown in Figure 6.6 (a). 
6.2.2 Optimization and evaluation of the liquid flow sensor 
 
Figure 6.7 64 Volume sensor monitors the delivery volume of each pressing of the pump chamber. 
(a) Demonstration of the drug delivery with volume sensor monitoring; (b) Optimization for 
spacing between the top and bottom surface of the triboelectric pair; (c) Delivery volume 
calibration with different measuring method. 
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In equation (1), the spacing between the top surface of the TEH and another contact surface 
is also another parameter to determine the output voltage. In order to investigate the effect of the 
spacing between the TEH surface and contact surface, which is the height of the PDMS chamber, 
we changed the spacing from 250 μm to 1000 μm. In this test, the TEH samples are with pyramid 
surface micro-pattern and of 215 μm PDMS thickness, which are the samples generating the 
highest output voltage in Figure 6.7(a). The sample was assembled above the top layer of pump-
chamber as shown in Figure 6.1 and Figure 6.2 (A). The bottom layer of the pump-chamber was 
pressed to delivery solution of certain volume within the range from 0.01 ml to 0.1 ml. The output 
voltage was recorded and the relation between the delivery volume and output voltage is shown in 
Figure 6.7 (b). According to the equation(1) for fully contact-mode TEHs, the output voltage will 
increase with the increase of the spacing. But as shown in Figure 6.7 (a), the output voltage 
decreases with the increase of the spacing. This is because the TEH shown in Figure 6.1 and 
Figure 6.2 is not working in fully contact-mode. With the same deformation of the top layer of 
the pump-chamber, the contact area decreases with the increase of the spacing. Although the TEH 
could give higher output voltage when the spacing was lower, the standard deviation was also 
higher, which is shown as the error-bar in Figure 6.7 (b). Thus there is a trade-off between the 
accuracy and the output voltage of the TEH delivery volume sensor. When the pump chamber is 
pressed by finger, the TEH patch will deform and contact with the Al surface. However, these two 
surfaces not only contact with each other but also squeeze each other and further have a friction 
between them. So the whole TEH does not only work in contact mode but also partially works in 
friction mode. The friction will also contribute to the output voltage. This friction is more obvious 
when the spacing is lower. This is because with the same force applied on the pump chamber, the 
TEH patch will squeeze the Al surface more when the spacing is lower. If the force applied onto 
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the pump chamber is not perpendicular to the Al surface, then a friction will occur. However, the 
direction of the force applied by human finger cannot be too well controlled. Thus, the extent of 
friction also cannot be well controlled. This is the reason why the error bar is larger when the 
spacing is lower. When the spacing is 1000μm, this fiction almost does not happen because the 
deformation of the TEH surface is not large enough to squeeze the Al surface. Based on the data 
when the spacing is 1000μm, the Coefficient of Variation is %CV=11%. To have a better accuracy 
for the delivery volume monitoring, the design of 1000 μm spacing was applied for the sample in 
other tests. 
A demonstration of the drug delivery with volume sensor monitoring is shown in Figure 
6.7 (a). The weight of the patch was measured after each pressing to calculate the volume of the 
delivered solution. And the output voltages of the delivery volume sensor were also recorded and 
converted to delivered volume according to the voltage-volume curve calibrated in Figure 6.6 (b). 
Moreover, the number of empty drug reservoirs can be counted to roughly estimate the delivered 
drug volume. The results of the delivery volume of each finger-pressing measured by these three 
methods are shown in Figure 6.7 (c). The number of empty drug reservoirs for each pressing is 4, 
2, 3, 2 and 6, which is indicated as red line in Figure 6.7 (c). The volume measured by the weight 
and delivery volume sensor is indicated as blue spots and dash line, respectively. The delivered 
volume measured by delivery volume sensor and weight is almost the same except to the last data 
point, i.e., the volume measured by delivery volume sensor is a bit higher than the volume 
measured by weight. The applied force recorded by the delivery volume sensor at the last finger-
pressing data point was higher than the required force to deliver the rest solution in the patch, 
where the accurate volume is characterized as weight. Secondly the delivered volume measured 
by counting the empty chamber does not perfectly match with the data measured by delivery 
144 
 
volume sensor and weight because there was some residual solution in the empty drug reservoirs 
and channels. Generally the delivered volume can be roughly and straightforwardly estimated by 
counting the number of empty drug reservoirs. Thus the triboelectric volume sensor is required to 
figure out relatively precise delivered volume as long as some usage scenarios need the 
information of accurate delivered volume. 
6.2.3 Characterization and optimization for the TEH of stacked layers design 
 
Figure 6.865 Characterization and optimization for the TEH of stacked layers design. 
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Due to the small area of the whole device, the power generated by a single layer of TEH is 
limited. Thus TEHs of stacked layer design [137-142] have been applied to enhance the output voltage. 
Multi-TEHs (N layers) are stacked layer by layer and connected in parallel to achieve a N-times 
charge transferred by one pressing comparing with the single layer TEH. If all the N-layered TEH 
has the charge transport simultaneously, the output voltage will increase N times. Meanwhile, due 
to the parallel connection of all layers in the N-layered TEH, the total inner resistance will decrease, 
which further enhances the output power.  
Here we study the TEH with one, two and three stacked layers. The contact surface of the 
TEH is parylene vs Al. The thickness of PDMS dielectric layer is 215 μm which is optimized for 
the highest output (Figure 6.6 (a)). And to avoid a collapse and contact between two triboelectric 
surfaces when pressing is not applied, the spacing between two triboelectric surfaces is 700 μm.  
In order to calculate the power generated by the TEH, a load resistor was connected 
between the top and bottom electrodes. A cyclic force of approximately 6 N with 0.5 Hz frequency 
was applied to generate the power. The voltage was then measured across the load resistor to obtain 
the power generated by the TEH. As the load resistance was increased, the power output increased 
and peaked at a point and started dropping thereafter. The voltage and power characteristics of 
TEH with different stack layers are shown in Figure 6.8 (a). The maximum power output for 
devices with one, two and three stacked layers are 11.34 μW, 22.96 μW and 33.12 μW, respectively; 
the load resistance are approximately 28.57 MΩ, 25.93 MΩ and 16.67 MΩ, respectively, as shown 
in Figure 6.8 (b). This decrease of load resistance for peak power represents the decrease of the 
inner impedance of stacked TEHs, which is induced by the parallel connection of stacked TEHs. 
Although the quantity of charge transferred is proportional to the number of layers (black line in 
Figure 6.8 (d)), the peak voltage with respect to the number of layers does not follow the same 
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trend. The peak voltage of TEH with 3 layers for open circuit is 33V which is not as high as 3 
times of the peak voltage (15 V) of TEH with 1 layer in open circuit (Figure 6.8 (c)). Since all the 
triboelectric surfaces cannot be triggered simultaneously for the TEH with more than 1 layer, the 
voltage pulses of different layers will be generated at different times. Thus the width of voltage 
pulse, which is the accumulation of the voltage pulses of all layers, will increase with the number 
of stacked layers (red line in Figure 6.8 (c)). The finger-pressing frequency will also change the 
output voltage as shown in Fig. 5(f). As shown in this figure, the peak voltage has an obvious 
increase within the range from 0.5 Hz to 2 Hz and tends to saturate when frequency is higher than 
2 Hz. One major parameter which seem to affect the output voltage was the impact force provided 
by the fingertip. As the amplitude of acceleration or force increases, the impact force also keeps 
increasing. Higher impact force results in increased elastic deformation in the PDMS layer which 
leads to increased contact area between the two triboelectric layers. The increased contact area is 
possibly the reason for increased triboelectric generation and performance of the device. The 
output voltage over time generated by different pressing frequency is added in the supplementary 
information. A representative example of the time domain signals of open circuit output voltage 
from different frequency with 1 stacked layer is shown in Figure 6.9.  Considering that the TEH 
is manually pressed, 2 Hz should be a reasonable optimum operation frequency. 
Due to the reliability concern , a parylene coating on the bottom PDMS dielectric layer was 
used to protect the metal layer at the backside in our design as shown in the S3. An experiment has 
been conducted for the TEHs without parylene coating as a comparison to previous data with 
parylene in order to characterize the impact of such parylene coating. Thus, the contact surface is 
PDMS vs Al. The voltage and power characteristics of TEH with different stack layers are shown 
in Figure 6.8 (e). Compared with the results of TEH with parylene coating, the load resistances of 
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peak powers are the same. However, the peak powers are 14 μW, 29.3 μW and 42.8 μW, 
respectively, indicating an average of 27% enhancement. This result suggests that, if the backside 
metal of the TEH patch is not easily detached or scratched, the parylene layer can be avoided and 
PDMS surface can offer a better performance. 
 
Figure 6.966 Comparison of time domain signals of open circuit output voltage from different 
frequency with 1 stacked layer. 
The force impact increases with the increase of the pressing frequency. Thus, higher impact 
force results in increased elastic deformation in the PDMS layer which leads to increased contact 
area between the two triboelectric layers. The increased contact area induce enhances the 
triboelectric generation and performance of the device. When the pressing frequency is 0.5 Hz, the 




6.2.3 Characterization of the liquid volume sensor in insulin delivery test 
 
Figure 6.1067 Delivery volume sensor monitors and controls the dose for insulin delivery. (a) 
Optical image of the microneedle array assembled onto the patch, the scale bar is 200μm; (b) 
Detailed optical image of an individual microneedle, the scale bar is 200μm; (c) Histology image 
of individual microneedle penetration, scale bar is 200μm; (d) Changes in blood glucose level in 
diabetic rats after insulin delivery using microneedles, subcutaneous hypodermic injection of 
insulin, and without injection of insulin; (e) Changes in blood glucose level in diabetic rats after 
insulin delivery using microneedles with different delivery volumes. 
In order to confirm that the device has ideal features for an efficient drug volume control, 
transdermal delivery of insulin was tested in vivo. As a powerful approach for various biomedical 
researches such as transdermal drug delivery and transdermal bio-sensing, a microneedle array 
was assembled onto the skin patch for the skin penetration and insulin delivery. The sharp tips of 
microneedles were assembled by double drawing lithography onto the patch as shown in Figure 
6.10 (a) and (b). Penetration tests on mouse cadaver skin were conducted to characterize the 
penetration capability of the SU-8 microneedles made by double drawing lithography. A histology 
image of the skin at the site of one microneedle penetration confirms that the sharp conical tip was 
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not broken during the insertion steps as shown in Figure 6.10 (c). A detailed in vitro drug delivery 
test is shown in Figure 6.11. 
All the procedures were performed under protocol and approved by the Institutional 
Animal Care and Use Committee at the National University of Singapore. Sprague–Dawley rats 
with weight of 200 ~ 250 g were injected with 50 mg kg−1 streptozotocine (Sigma-Aldrich, 
Singapore) in citrate buffer (pH 4.2) via intraperitoneal injection to generate a diabetic animal 
model. These rats were kept with free access to food and water for 3 days. Then their blood glucose 
level was checked by a glucometer (Accu-Chek, USA). The rats with blood glucose level between 
16 and 30 mM were selected and the hairs on the abdomen skin were removed by a razor 24 hours 
before the experiment. All these rats were divided into 3 groups and each group contained 3 rats. 
We first conducted the tests without liquid volume control to confirm the drug delivery 
capability of the patch. Group 1 was a negative control group, in which we only tested the blood 
glucose level throughout the duration of the test. Group 2 was an experimental group. After the 
rats were anesthetized, the patch with insulin loaded was applied on the abdomen skin surface. The 
pump chamber was pressed to deliver all the insulin (10 IUmL−1) contained in the drug reservoirs. 
As mentioned before, the totally volume of all the drug reservoirs is about 246 μL. In group 3, 
after the rats were anesthetized, 10 IUmL−1 Lispro insulin was injected subcutaneously with a 29G 
hypodermic needle into the rats (2.5 IUkg−1) as a positive control experiment. 
Blood samples were taken from the tail vein every 30 minutes after the beginning of the 
experiments in all groups. The blood glucose level monitoring lasted for 5.5 hours. A glucometer 
(Accu-Chek, USA) was used to give the corresponding blood glucose levels. The results are shown 
in Figure 6.10 (d). The blood glucose level in rats treated with our patch dropped continuously 
during the 5.5 hours insulin delivery period and was quite stable after 3 hours. It was significantly 
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different compared with the negative control group, where insulin solution was not administered 
to the rats. Remarkably, the changing of the blood glucose level in the positive control experiments 
in both groups, i.e., using patch and a hypodermic needle, was about the same. This experiment 
successfully proved the feasibility of using proposed LoC drug delivery patch to deliver 
macromolecules like insulin.  
A detailed study was conducted in order to study the ability of manual control function for 
insulin delivery, which is supported by the microfluidic control system including pump chamber, 
check-valves and liquid volume sensor. During the test with patches, the delivery volume was 
controlled by controlling the pressing force. The output voltage of the liquid volume sensor was 
recorded to confirm the different volume delivered during the tests, as shown in Figure 6.10 (e). 
There were 4 groups in the study. For the first 2 groups, only one time pressing was applied during 
the test. The output voltages of the delivery volume sensor were 3.8 V and 5.4 V, respectively. For 
the last 2 groups, the pump chambers were pressed twice and the output voltages of the delivery 
volume sensor were measured as 5.3+3 V and 5.6+5.3 V, respectively. The change of the blood 
glucose level is shown in Figure 6.10 (e). For the group with higher voltage output, which means 
a larger volume of insulin delivery, the blood glucose level drops more. But for all the groups, the 
blood glucose level stabilized at a certain level after 3 hours. The experiment confirms that the 
manual control delivery mechanism with liquid volume sensor can successfully monitor insulin 
delivery and further control the blood glucose level. However, during the insulin delivery, the 
microneedles were immersed within the skin, making the outlets of the microneedles. Thus, the 
flow resistance of the whole microfluidic channel has a significant increase, result in a slight 
deviation of the actual delivery volume from the in vitro calibration as shown in Figure 6.12. 
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Generally speaking, the actual delivery volume of in vivo was around 10% lower than that of in 
vitro calibration in the situation of drug delivery when microneedle were in skin. 
 
Figure 6.1168 Images of confocal microscopy to show the florescent solution is successfully 
delivered into the tissue underneath the skin surface. (a) 30 lm; (b) 60 lm; (c) 90 lm; (d) 120 lm; 
(e) 150 lm; and (f) 180 lm (scale bar is 100 lm). 
In order to verify that the drug solution can be delivered into tissue from the sidewall gaps 
of the microneedles, FITC (Fluorescein isothiocyanate) (Sigma Aldrich, Singapore) solution was 
delivered through the SU-8 microneedles after they were penetrated into the mouse cadaver skin. 
The representative results were then investigated via a confocal microscope (Figure 6.11). The 
permeation pattern of the solution along the microchannel created by microneedles confirmed the 
solution delivery results. The black area was a control area without any diffused florescent solution. 
In contrast, the illuminated area in Figure 6.11 indicates the area where the solution has diffused 
to it. These images were taken consecutively from the skin surface down to 180 lm with 30 lm 
intervals. The diffusion area had a similar dimension with the inserted microneedles. It has proved 




Figure 6.12 69 Comparison of the insulin delivery volume measured by weight and liquid 
volume sensor in in vivo test. 
When the microneedles were in skin during in vivo test, the flow resistance of the whole 
micrfludic channel increases a lot. Thus, the actual insulin delivery volume was a bit lower than 
the value of the in vitro calibration. The detailed comparison is show in Figure 6.12. The actual 
delivery volume measured by weight (red line) is always lower than that measured by liquid 
volume sensor (black line). The deviation was small when the delivery volume is low and increases 
with the increase of the delivery volume. 
6.3 Conclusion 
Triboelectric energy harvester has been applied for various kinds of wearable sensors and 
electronics due to its flexible and thin film structure. Here a liquid volume sensor which leverages 
the triboelectric mechanism was integrated within a wearable lab-on-chip drug delivery patch to 
realize a manually controlled large volume drug delivery function. To power active components 
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which will be integrated on the patch in the near future, a stacked layer triboelectric energy 
harvester (TEH) design was studied and characterized. Increasing the number of stacked layers 
significantly enhances the output power. The output power generated by a TEH with 3 stacked 
layers and a 2×2 cm2 area is 33 μW. The optimum pressing frequency is 2 Hz which is within the 
reasonable range of usage scenarios based manually finger pressing. The liquid volume sensor 
integrated within the patch leverages the similar structure as the TEH. The spacing between 
triboelectric pair surfaces is optimized to be 1000μm for a best accuracy. Thus, the delivery volume 
can be monitored, which is crucial for certain medical applications such as insulin delivery, whose 
delivery dose needs to be precisely controlled. Microneedle array was assembled onto the patch to 
confirm the drug delivery and volume monitoring functions by in vivo experiments in rats. The 
liquid volume sensor can be integrated with other drug delivery devices or lab-on-chip microfluidic 







Chapter 7 Summary of current work and Future plan 
7.1 Summary of current work 
 In this thesis, we have explored how to further develop the drawing lithography process 
and integration of microneedle with other functional components to realize different applications. 
We first designed and developed two different kinds of flexible microneedle patch by using 
dissolvable and non-dissolvable materials as the sharp tips. Both of them are hollow microneedles 
for the continuous delivery of large molecules. The flexible microneedle patch with dissolvable 
sharp tips is able to deliver drugs with large volume while four beams structure with SU-8 tips 
enhance the microneedle stiffness. The proposed fabrication process is scalable, reproducible and 
inexpensive. The height of the microneedle by drawing lithography is around 800µm which is 
comparative with the hollow microneedles fabricated by other processes. But our process is much 
simpler, of lower coat, and more importantly, enables further integration with other functional 
components. 
Based on the non-dissolvable microneedle we developed, we further investigate the 
microneedle with CNTs nanofilters. Such CNTs nanofilters can be used to selectively transport 
biomolecules such as ss-DNA, glucose, insulin and Haemagglutinin. This is the first time to realize 
biomolecule transport through CNTs. Previously only gas, ion and gold particles transport through 
CNTs.[143-145] Because the condition to have molecules transport for different biomolecules are 
different, according to their dimension, shape and polarity, the drugs can be selectively delivered 
during the drug administration by using the microneedle with CNTs nanofilter assembled within.  
For the next step, a soft microneedle skin patch which can have a conformal attachment 
onto skin as a wearable medical device is expected to be realized. However, the uneven skin 
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surface will introduce unpredictable buckling force which will cause needle breakage during the 
skin penetration for the soft skin patch. Therefore, we propose a unique bendable microneedle 
design to overcome this issue. The design composes a rigid sharp tip, which can be either glucose 
or SU-8, and a soft PDMS base. Such bendable microneedle can bend when the needle cannot 
penetrate skin. After skin penetration, the bendable microneedle can also adjust the lateral 
movement between skin surface and microneedle skin patch to avoid needle broken within skin. 
With optimization of the PDMS mix ratio and pillar angular, the skin penetration rate for bendable 
microneedle with SU-8 tip is 88% and with maltose tip is 66%. Although the skin penetration rate 
cannot be as high as rigid hollow microneedles, the bendable microneedle can avoid safety issue 
caused by needle breakage within skin.  
By using this bendable microneedle, we realize a thin and soft microneedle skin patch as a 
standalone device which can realize the function of drug loading and delivery only with manual 
control. As a medical device, other chemical sensors for health monitoring are expected to be 
integrated onto the skin patch in the future. Thus a power source for these active components are 
necessary. In this skin patch, we also integrated TEH leveraging dry adhesive micro structure as 
power source which can power these sensors which may be incorporated in the future. The TEH 
leveraging dry adhesive micro structure can generate 11.79 μW with 23.08 MΩ inner impedance 
while the TEH leveraging  conventional  pyramid micro structure can generate 15.21 μW  with 
44.44 MΩ  inner impedance. Although the maximum output power of pyramid is higher than that 
of dry adhesive, the lower inner impedance of dry adhesive can realize a higher output power when 
the load resistance is smaller than the inner impedance of dry adhesive. 
To further make the drug delivery system complete and more like a standalone  wearable 
medical device, a volume sensor is inevitable to measure the drug dose to be delivered, especially 
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for the insulin delivery. Hence we investigate a TEH based volume sensor which can be integrated 
within the skin patch. We delivery volume can be immediately measured when we press the finger 
onto the pneumatic pump to deliver drug. With this feedback signal of delivery volume, the drug 
dose can be manually controlled.  The spacing between triboelectric pair surfaces is optimized to 
be 1000μm for a best accuracy when the Coefficient of Variation is %CV=11%. A minimal 
delivery volume of 10μL can be realized.  
7.2 Flexible microneedle skin patch of ultra-high needle density with surface drug coating 
for short term drug delivery 
For the application of short term drug delivery which only the total drug dose needs to be 
controlled, we could also make flexible microneedle skin patch without hollow channels but 
coating with a drug-containing layer onto the surface of microneedles as shown in Figure 7.1(a). 
Compared with the flexible microneedles with hollow channels, this kind of microneedle skin 
patch could be much thinner and more conformal to skin due to the absence of the thick PDMS 
layer for chamber reservoir. It could be applied as a normal bandage and will become a disposable 
device.  
To realize a sufficient drug dose on one skin patch, the microneedle array needs to be dense 
enough. For the previous microneedle made by drawing lithography, the spacing of the 
microneedles cannot be less than 1 mm. Otherwise the drawing material will form a cluster among 
a few semi-formed microneedles during the drawing process. Here we propose a new idea to 
improve the process and overcome this issue, significantly increase the density and production 
quality of microneedles on one patch. Either the gel-like materials or solution-like drug will be 
investigated and optimized. To control the volume of the drug, the thickness of the drug coating 
layer could be further tuned by controlling the cycles of coating process. An improved process is 
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proposed in this project as shown in Figure 7.2. SU-8 is baked on glass slide (Figure 7.2 (a)) and 
covered by a grid mold (Figure 7.2 (b)). The holes on the grid layer would be filled by melted SU-
8. Then align the microtube array (Figure 7.2 (c)) and inserted it into the melted SU-8 (Figure 7.2 
(d)). Due to the physical separation of SU-8 in each well, during the drawing lithography process, 
the formation of each sharp tip will not be affected by others (Figure 7.2 (e)). Thus the density of 
the needle array is simply determined by the density of the holes on grid mold.  
 
Figure 7.170 (a) 2D illustration of microneedle skin patch of ultra-high needle density with surface 
drug coating; (b)-(d) Optical images of a prototype of microneedle we currently achieved. 
 
Figure 7.271 Improved drawing lithography process for ultra-high density needle array.  
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7.3 Further study of the selective drug delivery 
A few kinds of ions and molecules pumping through CNTs by different driving methods have 
been reported. Gas (e.g. H2, N2, CO2, Ar and CH4), polar molecules (e.g. water, ethanol and 
isopropyl alcohol), non-polar molecules (e.g. hexane and decane) and non-charged nano-particles 
(e.g. Au particles) can pass through CNTs by applying pressures, while charged ions (e.g. Na+, K+, 
H+ and Li+) and various kinds of molecules (e.g. water, DNA, ss-DNA and charged lysozyme) can 
pass through CNTs with the aid of an electric field. But selectively transport biomolecules through 
CNTs nanofilters are only reported by our group. Previously, the biomolecules can pass the CNTs 
nanofilters just by applying electric field and pressure. However, it is also reported that surface 
function of CNTs could realize a selective biomolecule transport as shown in Figure 7.3. In Figure 
7.3 (a), the surface of CNTs was modified by electrochemically oxidation. Then two biomolecules, 
lysozyme and BSA, could be separated by applying electric field. Only Lysozyme could pass 
through the CNTs. And in Figure 7.3 (b), the surface of CNTs was modified by ethanolamine. And 
the permeability of ss-DNA and Au nanopaticles could be controlled. Such a modification also 
could be incorporated in the fabrication of the microneedle with CNTs nanofilters.  
In our future study, we could explore the other surface functionalization on CNTs nanofilters 
and enable a selective drug delivery without applying electric field. Thus only pressure is required, 
the microneedles with CNTs nanofilters are able to be integrated onto flexible skin patch as a 





Figure 7.3 72  (a) The surface of CNTs is modified by electrochemical oxidization and two 
biomolecules could be separated by CNTs membrane; (b) The surface of CNTs is modified by 
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Appendix 1 : Detailed fabrication process for CNT 
nanofilter 
 
Figure A1. Fabrication process for stretchable membrane based nanofilters using patterned array 
of vertically grown carbon nanotubes 
Figure A1 illustrates the fabrication process. The process began with thermal oxidation of 
single crystal silicon substrate to form a etch stop oxide layer. After the CVD of poly-silicon as a 
sacrificial layer, a 5 nm thickness of pattered Fe film, which acted as the catalyst film for the 
selective growth of CNTs, was prepared onto the silicon substrate (Figure A1(a)). As illustrated in 
Figure A1(b), the vertical aligned CNT bundles of 50 μm in height were grown via pyrolysis of 
acetylene at 800ºC with an Ar/NH3 flow for 15 min. The CVD parylene-C was then employed to 
fill into vertically aligned CNTs to reinforce the inter-tube binding at room temperature. Thus, the 
top side of CNTs was covered with parylene-C, and the discrete CNTs were bound together by 
parylene-C (Figure A1(c)). This step was the most critical process for forming the mechanical 
supporting layer for CNT bundles. The thickness of the flexible parylene-C layer was determined 
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by the CVD process. To achieve reliable mechanical strength for following handling and process, 
10 μm thick parylene layer was deployed. The parylene layer was peeled off together with CNT 
bundles from the substrate. Since the catalyst layer blocked the bottom ends of CNTs, the catalyst 
layer at the bottom of CNT bundles was etched by oxygen plasma from backside (Figure A1(d)). 
Then a prebaked SU-8 layer of 200 μm thickness on PET was prepared. PET is a kind of 
transparent soft film having low adhesion with SU-8. The PET film was fixed on glass slide by 
tapes to provide a rigid substrate for processing. The parylene layer was attached on the surface of 
SU-8 layer. The SU-8 layer was then melted at 95 ºC and cooled to room temperature. A good 
bonding between parylene and SU-8 was achieved (Figure A1(e) and 1(f)). After this bonding, 
well aligned microchannels under CNT bundles were patterned by UV lithography (Figure A1(g)). 
The diameter of the channel is 40 μm, smaller than the diameter of the CNT bundles, to ensure the 
SU-8 under parylene sidewalls around CNT bundles was exposed. The bonding between SU-8 and 
parylene sidewalls would finally provide sufficient mechanical bonding strength to fix the CNT 
membranes on SU-8 substrate. After UV lithography, the sample was post baked at 65 ºC for 10 
min and 95 ºC for 30 min. Then the PET film together with SU-8 and parylene layer was released 
from glass slide by removing the tapes. The SU-8 layer together with the parylene layer was dry 
released from PET by slightly bending the PET film (Figure A1(h)). The released SU-8 layer was 
developed to form the microchannels. A bonding technique was developed for bond SU-8 with 
PDMS. A thin PDMS film of 200 μm thickness with center area larger than the dimension of CNT 
bundle array cut off was prepared. The surface of this PDMS layer was treated with nitrogen 
plasma and attached to the bottom surface of SU-8 layer. The sample was baked at 120 ºC for 30 
min. A permanent bonding between SU-8 and PDMS was achieved (Figure A1(i)). In this step, the 
thickness of PDMS must be kept low enough to avoid the poor quality bonding, which is due to 
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the non-conductivity and the low plasma efficiency of the PDMS layer. After the bonding, the 
parylene layer was etched by oxygen plasma to open the sealed top ends (Figure A1(j)). In this 
process, the whole parylene layer was etched away except the parylene sidewall around the CNT 
bundles due to the anisotropic property of RIE . The adhesion between parylene and SU-8 was 
good enough to hold suspended CNT bundles as mentioned above. In the RIE etching process, the 
plasma generated large amount of heat. The temperature of SU-8 layer would rise to several 
hundred ºC during the long period of the 10 μm thick parylene etching. This high temperature 
would degenerate the bonding between SU-8 and PDMS. Thus, the whole etching process was 
divided into several periods to avoid over heating for samples. After etching away parylene on 
CNT bundles, the membrane was bonded with a thick PDMS layer (Figure A1(k)). This process is 
a conventional bonding between PDMS surfaces. Both PMDS surfaces were treated with oxygen 





Appendix 2 : Preparation of ss-DNA and BPSM 
ss-DNA preparation: Single strand DNA (ss-DNA) was prepared by the following steps: 
Bordetella pertussis genomic DNA was used as a template to synthesize a PCR fragment of 805 
base pair using Go Taq Green Master Mix (Promega) kit protocol. Primers used for the PCR were 
from Sigma Aldrich, HPLC purified vipC forward primer 
(5'TTGAATTCGAGTTCGAGCCGGTGCTGG3') and vipC reverse primer 
(5'TTAAGCTTTTGCTGGTAAGGAATGCGCTG3'). Annealing temperature of 64.5ºC was used 
and the denaturation, annealing and extension cycle was repeated 25 times. Final elongation step 
was carried out at 72ºC for 10 min. The ds-DNA generated was then kept at 95ºC for 5 min to 
separate the two DNA strands to generate ss-DNA. PCR reaction was set up using Bio-Rad 
iCycler-thermal cycler PCR. Haemagglutinin was purchased from Zuellig Pharma. Other chemical 
reagents were purchased from Sigma Aldrich and used without a further purification. NaCl and 
HCl solutions were prepared using deionized (DI) water from a water purification system 
(Millipore SAS 67120 MOISHEIM). 
Bacterial preparation: BPSM (Bordetella pertussis streptomycin resistant strain) was grown on 
sheep blood agar plates for 4 days. A loopful growth was taken to inoculate 10 ml SSAB media 
with streptomycin. The culture was grown for 24 hours at 37 ºC with continuous shaking. The OD 




Appendix 3 : List of Publication and Award 
Journal Paper  
 
1. Hao Wang, Giorgia Pastorin, and Chengkuo Lee,“ Stretchable Self-powered Wearable 
Adhesive Skin Patch with Bendable Microneedle Array for Transdermal Drug Delivery”， 
submitted to Advanced Science. 
2. Hao Wang, Zhuolin Xiang, Giorgia Pastorin, Xiaojing Mu, Zhong Lin Wang, Lee  Chengkuo,  
“Development of triboelectric liquid volume sensor for self-powered lab-on-chip 
applications”, Nano Energy (Under review) 
3. Hao Wang, Chia-Hung Chen, Zhuolin Xiang, Min Wang and Chengkuo Lee, “Convection-
driven long-range linear gradient generator with dynamic controls”, Lab on a Chip, vol. 15, 
no. 6, pp 1445 - 1450, 2015.   
4. Hao Wang, Zhuolin Xiang, Chih-Fan Hu, Giorgia Pastorin, Weileun Fang, and Chengkuo 
Lee, “Microneedle Array Integrated with CNT Nanofilters for Controlled and Selective Drug 
Delivery”, IEEE/ASME J. Microelectromech. Syst., vol.23, No.5, pp. 1036-1044, 2014 
5. Hao Wang, Zhuolin Xiang, Chih-Fan Hu, Aakanksha Pant, Weileun Fang, Sylvie Alonso, 
Giorgia Pastorin and Chengkuo Lee, “Development of stretchable membrane based 
nanofilters using patterned arrays of vertically grown carbon nanotubes” , Nanoscale, vol. 5, 
no. 18, pp. 8488-8493, 2013 
6. Zhuolin Xiang, Hao Wang, Aakanksha Pant, Giorgia Pastorin, and Chengkuo Lee, 
“Development of vertical SU-8 microtubes integrated with dissolvable tips for transdermal 
drug delivery” , Biomicrofluidics, vol. 7, no. 2, 026502, 2013. 
7. Zhuolin Xiang, Hao Wang, Giorgia Pastorin and Chengkuo Lee, “Development of a Flexible 
and Disposable Microneedle-Fluidic-System With Finger-Driven Drug Loading and Delivery 
Functions for Inflammation Treatment”, IEEE/ASME J. Microelectromech. Syst., vol. 24, 
no.3, pp. 565-574, 2015. 
8. Zhuolin Xiang, Hao Wang, Suresh Murugappan, Shih-Cheng Yen, Giorgia Pastorin, 
and Chengkuo Lee, “Dense vertical SU-8 microneedles drawn from heated mold with 
precisely controlled volume”, J. Micromech. Microeng, vol. 25, no. 2, pp. 025013, 2015 
9. Zhuolin Xiang, Hao Wang, Aakanksha Pant, Giorgia Pastorin, and Chengkuo Lee, 
“Development of vertical SU-8 microneedles for transdermal drug delivery by double drawing 





1. Tao Wang, Hao Wang and Chengkuo Lee,"Highly Sensitive Piezoelectric Micromachined 
Ultrasonic Transducer (pMUT) Operated in Air",The 11th Annual IEEE Int'l Conference 
on Nano/Micro Engineered & Molecular Systems,  Matsushima Bay & Sendai, Japan from 
17-20 April, 2016 
2. Hao Wang, Tao Wang and Chengkuo Lee,"Self-Powered Liquid Volume Sensor Aiming 
at Lab-on-Chip Applications", The 11th Annual IEEE Int'l Conference on Nano/Micro 
Engineered & Molecular Systems,  Matsushima Bay & Sendai, Japan from 17-20 April, 
2016 
3. Hao Wang, Chia-Hung Chen, Zhuolin Xiang and Chengkuo Lee, Dynamic Controlled 
Long-Range Convection Flow-Driven Gradient In Lab-On-Chip , The 5th International 
Conference on Optofluidics 2015 , Taipei, Taiwan, July 26~29, 2015. 
4. Zhuolin Xiang, Hao Wang and Chengkuo Lee, A Disposable Drug Delivery System with 
Dense Vertical Microneedles Array and Finger-Driven Drug Loading and Delivery 
Functions, The 7th Intern. Symposium on Microchemistry and Microsystems (ISMM 
2015), Kyoto, Japan,June 8-10, 2015. 
5. Zhuolin Xiang, Hao Wang, Giorgia Pastorin, and Chengkuo Lee, Development Of A 
Disposable And Flexible Microneedle-Fluidic-System With Finger Driven Drug Loading 
And Delivery Functions, The 18th Intern. Conf. on Solid-State Sensors, Actuators and 
Microsystems (Transducers 2015), M4C.007, pp.89-92, Anchorage, Alaska, June 21-25, 
2015. 
6. Hao Wang, Yan Wang, Zhuolin Xiang, Ming Wang, Chia-Hung Chen and Chengkuo Lee, 
Chemical Gradient Generator By Using Diffusion And Convection, The 6th International 
Symposium on Microchemistry and Microsystems (ISMM 2014), pp. 232-233, Singapore, 
Jul. 29 Aug. 1, 2014. 
7. Hao Wang, Zhuolin Xiang, Chih-Fan Hu, Giorgia Pastorin, Weileun Fang and Chengkuo 
Lee, Microneedle Integrated with CNT for Controlled and Selective Drug Delivery, The 
6th International Symposium on Microchemistry and Microsystems (ISMM 2014), pp. 95-
96, Singapore, Jul. 29 Aug. 1, 2014. 
8. Hao Wang, Zhuolin Xiang, Chih-Fan Hu, Giorgia Pastorin, Askanksha Pant, Weileun 
Fang and Chengkuo Lee, Microneedle Array Integrated with Nanofilter for Selective Drug 
Delivery, Intern. Conf. on BioElectronics, BioSensor, BioMedical Devices, 
BioMEMS/NEMS and Applications 2013 (Bio4Apps 2013) &5th Sensing Biology 
Symposium,INV-2F-7 (Invited), Tokyo Medical and Dental University, Tokyo, Japan, Oct. 
30-31, 2013. 
9. Hao Wang, Zhuolin Xiang, Chih-Fan Hu, Aakanksha Pant, Weileun Fang, Giorgia 
Pastorin and Chengkuo Lee, Polymer Microneedle Array Integrated with CNT Nanofilter 
for Selective Drug Delivery, The 15th International Conference on Biomedical 




10. Hao Wang, Zhuolin Xiang, Aakanksha Pant, Giorgia Pastorin, and Chengkuo Lee, 
Feasibility of Flexible Patch-Like Transdermal Drug Delivery Devices, the 2nd Japan-
Singapore Research Exchange & ICT Farm Project, Kyushu University, Japan, Aug. 16-
17, 2013. 
11. Zhuolin Xiang, Hao Wang, Chengkuo Lee, Aakanksha Pant, Pastorin Giorgia, Integration 
of Dissolvable Sharp Maltose tips on SU-8 Microtubes for Transdermal Drug Delivery 
Application, The 5th International Symposium on Microchemistry and Microsystems 
(ISMM 2013), Xiamen University, China, 1-K-1, May 16-19,  2013. 
12. Hao Wang, Zhuolin Xiang, Chih-Fan Hu, Aakanksha Pant, Giorgia Pastorin, Weileun 
Fang, Sylvie Alonso, and Chengkuo Lee, Stretchable Nanofilter Membrane Using 
Patterned Array of Vertically Grown Carbon Nanotubes, The 5th International Symposium 
on Microchemistry and Microsystems (ISMM 2013), Xiamen University, China, P-I-49, 
May 16-19, 2013. (poster) 
13. Venkata Sudheer Makam, Wang Hao,Chengkuo Lee, and Giorgia Pastorin, Label free 
isolation of sample mixtures containing tumor cells and blood cells using a microfluidic 
device, The 5th International Symposium on Microchemistry and Microsystems (ISMM 
2013), Xiamen University, China, P-I-55, May 16-19, 2013. 
14. Zhuolin Xiang, Hao Wang, Songsong Zhang, Shih-Cheng Yen, Minkyu Je, Wei Mong 
Tsang, Yong-Ping Xu, Nitish V. Thakor, Dim-Lee Kwong, and Chengkuo Lee, 
Development of Flexible Neural Probes Using SU-8/Parylene, The 18th Annual IEEE 
International Conference on Nano/Micro Engineered and Molecular Systems (NEMS 
2013), Suzhou, China, 1076 - 1079, Apr. 7-10, 2013. 
15. Zhuolin Xiang, Hao Wang, Songsong Zhang, Minkyu Je, Wei Mong Tsang, Yong-Ping 
Xu, Shih-Cheng Yen, Nitish V. Thakor, and Chengkuo Lee, Development of polymer-
based electrode probes for neural interfacing, Intern. Conf. on BioElectronics, BioSensor, 
BioMedical Devices, BioMEMS/NEMS and Applications 2012 (Bio4Apps 2012), PP-13, 
CeLS, National University of Singapore, Singapore, Nov. 19-20, 2012. 
16. Zhuolin Xiang, Hao Wang, Chengkuo Lee, Aakansha Pant, and Giorgia Pastorin, 
Development of SU-8 microneedles integrated with dissolvable tips for transdermal drug 
delivery, International Conference on BioElectronics, BioSensor, BioMedical Devices, 
BioMEMS/NEMS and Applications 2012 (Bio4Apps 2012), PP-14, CeLS, National 
University of Singapore, Singapore, Nov. 19-20, 2012. 
17. Hao Wang, Zhuolin Xiang, Chih-Fan Hu, Chengkuo Lee, Aakansha Pant, Weileun Fang, 
and Giorgia Pastorin, Development of patterned vertically grown carbon nanotubes filters 
for mass transportation, Intern. Conf. on BioElectronics, BioSensor, BioMedical Devices, 
BioMEMS/NEMS and Applications 2012 (Bio4Apps 2012), PP-15, CeLS, National 





Best Paper Award recipients for 6th International Symposium on Microchemistry & 
Microsystems (ISMM) 2014 
Hao Wang 
Oral Paper Award 
The winning entry is entitled “Microneedle Array Integrated with CNT Filters for Controlled 
and Selective Transdermal Drug Delivery”. 
 
